name: Fluid-filled cavity within the cerebral hemispheres, can be unilateral or bilateral and may or may not communicate with cerebrospinal fluid (CSF) spaces


name: Generalized, unilateral or localized disproportionate overgrowth of any tissue


name: Hypoplasia, fusion, and contractures of post-axial fingers


name: Reduced upper- to lower-body segment ratio


name: Osteochondritis dessecans of the shoulders, elbows, and knees


name: Increased bleeding tendency due to platelet dysfunction


name: Hypertrichosis of cheeks and forehead, mild


name: Shift in anagen-to-telogen ratio towards anagen


name: Intermyofibrillar and subsarcolemmal accumulation of electron-dense material


name: Coronal and radicular dagger-shaped pulpal calcifications


name: Symmetric deterioration of hearing loss and speech reception with age


name: Severe to profound hearing impairment by early adulthood


name: Absent distortion product otoacoustic emissions (OAEs)


name: Absent ipsilateral middle ear muscle reflexes


name: Bilateral dys-synchronized auditory brainstem responses


name: No reproducible waves I, III, or V at high intensities


name: Absence of vestibular evoked myogenic potentials


name: Deep white matter lesions, particularly affecting the frontal and parietal lobes


name: Autofluorescent pigment in microglia and macrophages


name: Skin wrinkling (limited to dorsum of hands and feet and abdomen)


name: Decreased beta-oxidation of pristanic acid


name: Brittle hair of scalp, beard, eyebrows, eyelashes, and axillary and pubic areas


name: Loss of normal scale pattern on light and electron microscopy


name: Irregular, ridged surface on light and electron microscopy


name: Grooved surface appears twisted on light and electron microscopy


name: Alternating birefringent pattern on polarization microscopy


name: Reduced sensory nerve conduction velocities


name: Reduced numbers of tongue fungiform papilla


name: Recurrent infections (pulmonary, skin, teeth)


name: Enlarged head circumference (97th percentile)


name: Giant pigmented nevi, often in lumbosacral region


name: Cytochemical and EM muscle studies show large, bizarre mitochondria in striated muscle


name: Relative sparing of the tibialis anterior


name: Increased susceptibility to severe and frequent infections with Staphylococcus aureus


name: Low insulin-like growth factor-I (IGF1 147440) levels


name: Abnormal growth hormone (139250) response to stimulus


name: Abnormal gray and white matter differentiation in frontal, occipital, and cerebellar regions on CT scan


name: Variable cutaneous syndactyly involving fingers 3, 4, and 5


name: Insulin-resistant diabetes mellitus in adulthood


name: Normal phosphorylase kinase activity in muscle


name: Right-to-left shunt via the foramen ovale or ductus arteriosus or both


name: Malposition of pulmonary vein branches adjacent to pulmonary artery branches (MPV)


name: Deficient capillarization of airspace walls


name: Diffuse reticulogranular pattern seen on chest radiograph


name: Irregular, widened anterior ends of ribs


name: Delayed vertebral body ossification, mild


name: Bilateral cutaneous syndactyly of third and fourth fingers


name: Bilateral cutaneous syndactyly of second, third, and fourth toes


name: Normal isoelectric focusing of apolipoprotein CIII


name: Frayed, broken, and shortened elastic fibers


name: Patient cells show abnormal mitochondrial morphology


name: Increased urinary levels of MAOA substrates (endogenous bioamines)


name: Neuronal loss and gliosis in the cerebral cortex


name: Axonal loss and gliosis in the corticospinal tracts


name: UBQLN2- and TDP43-immunopositive inclusions in spinal motor, brainstem, and hippocampal neurons


name: Loss of galactose and sialic acid from multiple branches of complex type N-glycans


name: Subepithelial and anterior stromal opacities on slit-lamp examination


name: Corneal vascularization extending to central cornea


name: Hyperkeratotic lesions of posterior neck


name: Hyperkeratotic lesions of neck, elbows, knees, groin, genitalia, and buttocks


name: Flexion contractures of hands due to severe hyperkeratosis


name: Substantia nigra dopaminergic neuron loss


name: Cataract, postnatal, bilateral dense nuclear


name: Episodic acute neurologic deterioration/encephalopathy, recurrent


name: Avascular conjunctival cystic elevations (filtering blebs)


name: Electrophysiologic studies after episodes may show features of a demyelinating neuropathy


name: Slightly reduced nerve conduction velocities


name: Electrophysiologic abnormalities tend to return to normal after episodes


name: Sural nerve biopsy shows remyelinating lesions after episodes


name: Respiratory muscle weakness during episodes


name: Bleeding associated with peptic ulcer disease


name: Defective platelet aggregation in response to ADP


name: Neuropathic or myopathic changes seen on EMG


name: Noninflammatory myopathy with rimmed vacuoles and atrophic fibers seen on muscle biopsy


name: APOA5, +158C-T, 3-PRIME UTR (dbSNP rs2266788)


name: Bilateral calcification of basal ganglia and cerebellum


name: Swelling over proximal part of middle phalanx of second, third, and fourth fingers


name: Absence of epiphyseal ossification centers of distal and middle phalangeal bones of fifth finger


name: Synostosis of distal interphalangeal joint of fifth finger


name: Increased di- and asialo-transferrin characteristic of type 1 pattern


name: Bone-spicule pigmentation in midperiphery of retina


name: Reduced or extinguished electroretinography responses


name: Diffuse fine hard drusen in macula and paracentral area


name: Normal or decreased cone and rod responses on electroretinography


name: Normal or decreased Arden ratios on electrooculography


name: Hyperfluorescent ring in area of macular lesions on fluorescein angiography


name: Increased mitochondria with rare paracrystalline inclusions


name: Choanal atresia or choanal stenosis, bilateral


name: Selective decrease in small myelinated fibers seen on sural nerve biopsy


name: Multifocal epileptiform discharges on diffuse slow background


name: Low to undetectable insulin levels in the presence of hyperglycemia


name: Flexion contractures of upper and lower extremities


name: Decreased erythropoietic response under hypoxic conditions


name: Hypoplastic nails of some affected fingers and toes


name: Skeletal muscle may show less severe mtDNA deletion


name: Midcytoplasmic retraction of tonofilament skeleton


name: Obstruction of airways due to sloughed mucosa


name: Absence of upper and lower lateral incisors


name: Proximal and distal asymmetric muscle weakness of the upper and lower limbs


name: Severe muscle wasting and atrophy, primarily in the legs


name: Small or borderline to adequate size for gestational age


name: Respiratory insufficiency at birth, lethal


name: Elevated follicle-stimulating hormone (FSH) level


name: Reduced or absent follicles by ultrasound


name: Primordial or primary follicles on histology


name: Low maximum workload on exercise testing


name: Glycogen present in normal amount on biopsy


name: Decrease in stroke volume on exercise testing


name: Myocyte hypertrophy without disarray or fibrosis seen on biopsy


name: Serum C-reactive protein may be increased


name: Abnormal secondary ossification center of distal phalanges of thumbs


name: Central translucency of distal phalanges of halluces


name: Variably decreased serum IgA, IgG, and IgM


name: Low insulin-like growth factor-1 (IGF1) concentration


name: Lack of growth hormone (GH) response to stimulation


name: Absent or low response to gonadotropin-releasing hormone stimulation


name: Abnormal thyroid-stimulating hormone (TSH) response to thyrotropin-releasing hormone (TRH) stimulation, variable


name: Cerebellar atrophy, particularly of the hemispheres


name: Microcephaly, progressive (up to -11 SD)


name: Myopathic and neurogenic changes seen on EMG


name: Hearing loss, sensorineural, mild progressive


name: Thinning of retinal nerve fiber layer seen on optical coherence tomography


name: Sensitive teeth (thermal and physical stimuli)


name: Small cell carcinoma of the ovary, hypercalcemic type


name: Syncopal episodes, related to emotional or physical stress


name: Ventricular repolarization abnormalities on electrocardiogram


name: Fibroblasts shows defects in oxidative phosphorylation


name: Decreased amount and activity of mitochondrial complexes I and IV


name: Hyperplasia of zona fasciculata of adrenal gland


name: Hyperplasia of zona glomerulosa of adrenal gland


name: Paradoxical increase or no change in serum aldosterone and blood pressure after dexamethasone administration


name: Lower motor neuron involvement, mild, seen on EMG


name: Bleeding tendency due to platelet defect


name: Disseminated infection with dimorphic fungi (Coccidioides and Histoplasma)


name: Increased risk of hematologic malignancy


name: Alpha/beta, CD4-/CD8- T cells are minimally or not increased


name: High voltage spikes over the temporal and central regions seen on EEG


name: Global developmental delay, variable severity


name: Microcephaly, postnatal, progressive (-2 to -3.5 SD)


name: Decreased levels of certain coagulation factors


name: Partial or complete serum gonadotropin deficiency


name: Reduced number of follicles seen on ultrasound


name: Very long-chain fatty acids may be normal or increased


name: Increased bile acid intermediates (DHCA and THCA)


name: Increased plasma branched-chain fatty acids


name: Sural nerve biopsy shows lack of myelinated fibers


name: Patient fibroblasts and muscle show decreased activities of mitochondrial complexes I, III, and IV


name: Signal changes in the caudate and putamen


name: Upregulation of alpha-interferon-stimulated genes


name: Muscle atrophy in distal forearm and hands


name: Deep sensory impairment, mild to moderate


name: Small, angulated muscle fibers seen on muscle biopsy


name: Sarcomere disappearance seen on muscle biopsy


name: Disorganized myofilaments seen on muscle biopsy


name: Mitochondrial vacuolization seen on muscle biopsy


name: Decreased mitochondrial respiratory activities


name: Type II fiber atrophy seen on muscle biopsy


name: Fragmentation of the neuromuscular junction with pre- and postsynaptic defects


name: Decrement of the compound muscle action potential on repetitive stimulation


name: Muscle weakness and atrophy, progressive


name: Defective glycosylation of alpha-dystroglycan seen on biopsy


name: Muscle biopsy shows neurogenic angulated fibers


name: Decreased T-cell proliferative response to mitogens


name: Decreased activity of AMPD1 in skeletal muscle Increased serum creatine kinase


name: Increased levels of dihydroxyacetone phosphate (DHAP) in tissues and red cells


name: Decreased activity of triosephosphate isomerase


name: Increased susceptibility to B-cell lymphoma


name: Low levels of antibodies to S. pneumoniae, H. influenzae type B


name: Decreased numbers of long-term memory CD8+ T cells


name: Decreased circulating B cells (total CD19+)


name: Increased circulating transitional B cells (CD19+CD38+IgM+)


name: Decreased circulating class-switched memory B cells (CD19+CD27+IgD-)


name: Other sensory modalities may be normal or diminished


name: Deposition of IgG and complement seen on renal biopsy


name: Muscle weakness of proximal and distal upper and lower limbs


name: Focal lymphocytic and macrophage infiltrates on biopsy


name: Congenital poikiloderma on face and exposed skin


name: Hypotrichosis and/or alopecia, primarily involving scalp hair, eyebrows, and eyelashes


name: Recurrent infections, particularly herpes viral


name: Defective NK function in spontaneous cellular cytotoxicity


name: Antibody-dependent cellular cytotoxicity of NK cells is unaffected


name: NK cells showed unusual surface CD16 antibody reactions


name: Vertical clefting of the vertebral bodies


name: Defective ossification of the vertebral bodies


name: Generalized spike-wave discharges seen on EEG


name: Absence of atrial wall movement on fluoroscopy


name: Increased urinary tricarboxylic acid intermediates


name: Increased urinary 2-alpha-ketoglutaric acid


name: Impaired signaling through the T-cell receptor


name: Microcephaly, progressive (-3 to -10 SD)


name: Intellectual disability, moderate to severe


name: T cells may show impaired proliferative response to tetanus toxoid


name: Absent or difficult-to-count P waves on electrocardiogram (ECG)


name: Prolongation of P-wave on ECG in heterozygous carriers


name: Pigmentary changes in the peripheral retina


name: Undetectable responses on electroretinography (by fourth decade of life)


name: White spongy plaques on the vaginal mucosa


name: White spongy plaques on the esophageal mucosa


name: White spongy plaques on the rectal mucosa


name: White spongy plaques on the buccal, labial, and soft palatal mucosa and gingiva


name: Asymptomatic soft white spongy mucosal plaques with thick folded surfaces


name: Basket-weave appearance of spinous layer


name: Cell-within-a-cell appearance of spinous layer


name: Narrow intercellular spaces between vacuolated cells


name: Mild chronic inflammatory cell infiltrate of lymphocytes in submucosal connective tissue


name: White spongy plaques on the pharyngeal mucosa


name: Defective myelination of the deep white matter


name: Borderline elevated low-density lipoprotein


name: Increased susceptibility to infections (bacterial, fungal, and viral)


name: Increase in certain cytokines (IL4, IL5, IL13, IL17) upon stimulation


name: Hyposialylation of O-linked serum glycans


name: Decreased formation of complex (tri-, tetra-antennary) N-glycans


name: Serum transferrin glycosylation is normal


name: Fatty and fibrofatty replacement of cardiomyocytes in right ventricle


name: Excessive trabeculation in right ventricle


name: Decreased mitochondrial complex III activity (skeletal muscle, fibroblasts)


name: Secondary decreases in complex I and IV activity


name: Hearing loss, sensorineural, bilateral, moderate-to-severe


name: Mitochondrial complex III deficiency, isolated, seen on muscle biopsy


name: T2-weighted signal abnormalities in the deep white matter


name: MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 10


name: Abnormal T2-weighted signals in the occipital white and gray matter


name: High-density concentric perifoveal ring surrounding irregular foveal autofluorescence on autofluorescence imaging of fundus


name: Photoreceptor loss, primarily in foveal region, on optical coherence tomography


name: Failure to thrive secondary to congenital diarrhea


name: Patchy areas of dystrophic microvilli in duodenum


name: Decreased numbers of motile cilia in respiratory epithelial cells


name: Elongated tight junctions between adjacent hepatocytes and biliary canaliculi seen on biopsy


name: Normal or mildly increased serum gamma-glutamyltransferase (GGT)


name: PLASMA TRIGLYCERIDE LEVEL QUANTITATIVE TRAIT LOCUS


name: Tubular aggregates mainly in type 1 fibers


name: Aggregates contain granular electron-dense material


name: Hair loss, progressive, after 2 to 6 months of age


name: Axillary and pubic hair sparse or absent


name: Thin hair shafts, without other characteristic features


name: Hair follicles significantly decreased in number and size


name: No contrast between enamel and dentin on radiographs


name: Mucocutaneous bleeding due to platelet dysfunction


name: Impaired platelet aggregation and spreading


name: Isolated mitochondrial complex IV deficiency seen on biopsy


name: Incomplete median cleft of the upper lip involving the muscle


name: Incomplete median cleft of the lower lip


name: Fusion of the upper labial mucosa and the upper gingiva


name: Increased interdental distance between the upper and lower median incisors


name: Impaired ambulation due to muscle weakness


name: Lymphoscintigraphy shows impaired lymphatic uptake and drainage


name: Elevated erythrocyte adenosine deaminase


name: Muscle biopsy may show deficiency of multiple mitochondrial respiratory complexes


name: Hyperintense lesions of the globi pallidi


name: Multiple mitochondrial respiratory enzymes deficiencies seen on biopsy


name: Predisposition to UV-induced malignancies


name: Retinal degeneration with macular involvement


name: Electroretinography responses diminished or undetectable


name: Coxa valga deformity with epiphyseal dysplasia


name: Increased cross-linked C-terminal telopeptide of type I collagen


name: Increased bone-specific alkaline phosphatase


name: Loss of subcutaneous and visceral adipose tissue, mild


name: Amputation resulting from acral necrosis


name: Vasculitis, particularly of the capillaries


name: Enlarged head circumference (up to 7.5+)


name: Decreased delineation of the basal ganglia


name: High-normal plasma triglyceride concentration


name: Increased susceptibility to large granular lymphocytic T-cell leukemia


name: Elevation and splaying of the superior cerebellar peduncles


name: Slightly elevated 24-hour mean plasma cortisol


name: Bone-spicule pigmentation in peripheral retinal pigment epithelium


name: Reduced or nonrecordable cone responses on electroretinography


name: Abnormal fat accumulation below the triceps


name: Proximal muscle weakness, mild, of shoulder and hip girdle muscles


name: Increased T-2 signal in muscles of lower extremities on MRI


name: Abnormal fat accumulation in the labia majora


name: Abnormal fat accumulation in the clavicular regions


name: Macrophage infiltration of white adipose tissue


name: Cystic kidneys (may be observed prenatally)


name: Arched eyebrows with inverted V-shape laterally


name: Biopsy shows effacement of foot processes


name: Loss of myelinated fibers seen on sural nerve biopsy


name: Maturational arrest of granulocytes at the promyelocyte/myelocyte stage seen on bone marrow biopsy


name: Decreased expression of glycosylphosphatidylinositol-anchored membrane proteins


name: Metabolic acidosis due to renal bicarbonate loss


name: High signal intensities in periventricular white matter


name: High signal intensities at gray/white matter junction


name: Absent bone in areas of aplasia cutis congenita


name: Small brain with no other malformation see on MRI


name: Electron microscopy of patient respiratory cells shows absent outer dynein arms in the axoneme


name: Mixed axonal and demyelinating neuropathy


name: Decreased number of myelinated fibers seen on sural nerve biopsy


name: Decreased or normal nerve conduction velocities


name: Distal muscle weakness and atrophy of upper and lower limbs due to peripheral neuropathy


name: Low-amplitude compound muscle action potential (CMAP)


name: Postexercise CMAP amplitude facilitation


name: Presynaptic defect at the neuromuscular junction


name: Hearing loss, progressive, (high frequency loss at first progressing to loss of all frequencies)


name: Absent or abnormal otoacoustic emissions


name: Decreased activities of several mitochondrial respiratory enzymes


name: Disseminated intravascular coagulation, episodic


name: Muscle weakness, proximal, upper and lower limbs affected


name: Multifocal epileptiform spikes seen on EEG


name: Mirror movements, involuntary, affecting the hand and fingers


name: Intercellular edema from basal layer to mid-spinous layer


name: Slight decrease in number of gap junctions


name: Hyperreflectivity of ganglion cell layer


name: Markedly reduced or absent b-wave on scotopic electroretinography


name: Decreased to undetectable oscillatory potentials


name: Loss of myelin in the cerebral and cerebellar white matter


name: Loss of myelin in the descending lateral spinal cord tracts


name: Intellectual disability, mild to moderate (in homozygotes)


name: Recurrent bacterial and viral infections


name: Abnormal lymphocytic accumulation in non-lymphoid tissue


name: Difficulties with fine motor skills and coordination


name: Marked amplitude reduction and delay of a- and b-waves on electroretinography, more severe in scotopic than photopic system


name: Normal thyroid-stimulating hormone level


name: Episodic asymptomatic severe hypoglycemia in childhood


name: Nonautoimmune insulin-dependent diabetes in second decade of life


name: Subcortical temporal white matter disease, moderate


name: Lymphadenopathy subsequent to BCG vaccination


name: Cerebellar hypoplasia predominantly affecting the vermis


name: Movement abnormalities of the extremities


name: Spasticity, more apparent in the lower limbs


name: Axonal sensorimotor neuropathy affecting upper and lower limbs


name: Reduction in large myelinated fibers seen on sural nerve biopsy


name: Replacement of myofibers with connective tissue


name: Thin filament shortening and disorganization


name: Feeding difficulties due to muscle weakness


name: Relative sparing of fovea with surrounding atrophic ring


name: Central retinal pigment epithelium changes


name: Slightly or moderately attenuated vessels


name: Central hypofluorescence or hyperfluorescence on fluorescein angiography


name: Color vision deficit, green or red-green


name: Normal photopic and scotopic responses on electroretinography (ERG)


name: Severely reduced central responses on multifocal ERG


name: High follicle-stimulating hormone levels


name: Delayed development of pubic and axillary hair


name: Retinal pigment epithelial atrophy, widespread


name: Color vision disturbance in protan, deutan, and tritan axes


name: Severely reduced peripheral visual field


name: Absent rod responses and small residual cone response on electroretinography


name: Loss of inner segment/outer segment junction in the parafoveal area on ocular coherence tomography


name: Areflexia of the lower limbs Decreased nerve conduction velocities


name: Delayed psychomotor development, variable


name: T2-weighted hyperintense lesions in the thalamus, basal ganglia, and brainstem


name: Decreased activity of mitochondrial complexes I and IV seen on skeletal muscle biopsy


name: Muscle weakness, limb-girdle (lower and upper limbs may be affected)


name: Accumulation of PAS-positive polyglucosan material seen on muscle biopsy


name: Inclusions show positive immunostaining for SQSTM1 and ubiquitin


name: Inclusions form a lobulated structure seen on electron microscopy


name: Structural abnormalities seen on chromosome analysis


name: Intestinal pseudoobstruction, neurogenic and myogenic


name: Hypoplastic ganglia in enteric nervous system


name: Mislocalization of ganglia in circular and longitudinal cell layers


name: Mislocalization of Cajal cells in circular and longitudinal cell layers


name: Abundant T cells in smooth muscle layers


name: Extensive fibrosis in smooth muscle layers


name: Fragmentation of smooth muscle fiber architecture


name: C-band karyotype shows 'railroad track' appearance


name: Thin corpus callosum Enlarged ventricles


name: Muscle weakness, proximal, lower limbs (upper limbs may become affected later)


name: Increased mitochondria with abnormal cristae


name: Variably decreased activities of mitochondrial respiratory complexes I, II, and IV


name: Disorganized slow background activity seen on EEG


name: Normal response to exogenously administered insulin


name: Increased susceptibility to hematologic malignancies


name: Dysinnervation of various cranial nerves to ocular muscles


name: Decremental response of compound muscle action potential on repetitive nerve stimulation


name: Subsarcolemmal accumulation of normal mitochondria


name: Serum transferrin shows normal or mild hypo-glycosylation


name: Multiple fractures of extremities (may occur in utero)


name: Accordion-like broadened appearance of tubular bones


name: Upper and/or lower limbs may be affected


name: Vacuoles predominantly in type 2 fibers seen on muscle biopsy


name: Decreased density of calcium release units


name: Abnormal sarcoplasmic reticulum elements


name: Enlarged terminal cisternae of the sarcoplasmic reticulum


name: Enlarged vesicles of sarcoplasmic reticulum origin


name: Recurrent episodes of ventricular fibrillation


name: Prolonged QTc interval on electrocardiogram (ECG)


name: Exercise-induced polymorphic ventricular ectopy on ECG


name: Anomalies of the folding of the right Sylvian area


name: Head circumference at birth >97th percentile


name: White scaling skin, most prominent over upper and lower extremities


name: ALZHEIMER DISEASE, FAMILIAL, WITH SPASTIC PARAPARESIS AND UNUSUAL PLAQUES


name: ALZHEIMER DISEASE, FAMILIAL, 3, WITH UNUSUAL PLAQUES


name: ALZHEIMER DISEASE, FAMILIAL, 3, WITH SPASTIC PARAPARESIS


name: CEREBRAL AMYLOID ANGIOPATHY, APP-RELATED, PIEDMONT VARIANT


name: ALZHEIMER DISEASE, FAMILIAL, 1, AUTOSOMAL RECESSIVE


name: HEMOLYTIC ANEMIA, CD59-MEDIATED, WITH IMMUNE-MEDIATED POLYNEUROPATHY


name: ANTICHYMOTRYPSIN SIGNAL PEPTIDE POLYMORPHISM


name: HYPERCHOLESTEROLEMIA, FAMILIAL, MODIFICATION OF


name: APOLIPOPROTEIN A-I (MUNSTER3C) PHENOTYPE


name: APOLIPOPROTEIN A-I (MUNSTER3B) PHENOTYPE


name: APOLIPOPROTEIN A-I, ABSENCE OF, DUE TO DELETION OF APOA1/APOC3/APOA4 GENE COMPLEX


name: APOLIPOPROTEIN A-IV POLYMORPHISM, APOA4*1/APOA4*2 PHENOTYPE


name: APOLIPOPROTEIN A-IV RARE VARIANT, APOA4*0 PHENOTYPE


name: APOLIPOPROTEIN A-IV RARE VARIANT, APOA4*3 PHENOTYPE


name: APOLIPOPROTEIN A-IV RARE VARIANT, APOA4*5 PHENOTYPE


name: APOLIPOPROTEIN C-III, NONGLYCOSYLATED PHENOTYPE


name: HYPOBETALIPOPROTEINEMIA, FAMILIAL, ASSOCIATED WITH APOB39


name: HYPOBETALIPOPROTEINEMIA, FAMILIAL, ASSOCIATED WITH APOB40


name: HYPOBETALIPOPROTEINEMIA, FAMILIAL, ASSOCIATED WITH APOB90 OR APOB89


name: HYPOBETALIPOPROTEINEMIA, FAMILIAL, ASSOCIATED WITH APOB46


name: HYPOBETALIPOPROTEINEMIA, FAMILIAL, ASSOCIATED WITH APOB87


name: HYPOBETALIPOPROTEINEMIA, FAMILIAL, ASSOCIATED WITH APOB31


name: HYPOBETALIPOPROTEINEMIA, FAMILIAL, ASSOCIATED WITH APOB32


name: HYPERLIPOPROTEINEMIA, TYPE III, DUE TO APOE2-CHRISTCHURCH


name: HYPERLIPOPROTEINEMIA, TYPE III, ASSOCIATED WITH APOE2


name: HYPERLIPOPROTEINEMIA, TYPE III, ASSOCIATED WITH APOE DEFICIENCY


name: HYPERLIPOPROTEINEMIA, TYPE III, DUE TO APOE1-HARRISBURG


name: HYPERLIPOPROTEINEMIA, TYPE III, DUE TO APOE4-PHILADELPHIA


name: HYPERLIPOPROTEINEMIA, TYPE III, ASSOCIATED WITH APOE DEFICIENCY, AUTOSOMAL RECESSIVE


name: SPHEROCYTOSIS, TYPE 4, DUE TO BAND 3 TUSCALOOSA


name: SPHEROCYTOSIS, TYPE 4, DUE TO BAND 3 MONTEFIORE


name: SPHEROCYTOSIS, TYPE 4, DUE TO BAND 3 PRAGUE


name: SPHEROCYTOSIS, TYPE 4, DUE TO BAND 3 CHUR


name: SPHEROCYTOSIS, TYPE 4, DUE TO BAND 3 NOIRTERRE


name: SPHEROCYTOSIS, TYPE 4, DUE TO BAND 3 LYON


name: SPHEROCYTOSIS, TYPE 4, DUE TO BAND 3 GENAS


name: SPHEROCYTOSIS, TYPE 4, DUE TO BAND 3 FUKUOKA


name: SPHEROCYTOSIS, TYPE 4, DUE TO BAND 3 TOKYO


name: SPHEROCYTOSIS, TYPE 4, DUE TO BAND 3 COIMBRA


name: SPHEROCYTOSIS, TYPE 4, DUE TO BAND 3 CAPE TOWN


name: SPHEROCYTOSIS, TYPE 4, DUE TO BAND 3 PRAGUE III


name: SPHEROCYTOSIS, TYPE 4, DUE TO BAND 3 PRAGUE II


name: ABO BLOOD GROUP SYSTEM, A/B POLYMORPHISM


name: ABO BLOOD GROUP SYSTEM, CIS-AB PHENOTYPE


name: DOMBROCK BLOOD GROUP SYSTEM, DO(a)/DO(b) POLYMORPHISM


name: DOMBROCK BLOOD GROUP SYSTEM, DO-NULL PHENOTYPE


name: GERBICH BLOOD GROUP SYSTEM, YUSSEF PHENOTYPE


name: GERBICH BLOOD GROUP SYSTEM, GERBICH PHENOTYPE


name: GERBICH BLOOD GROUP SYSTEM, WEBB PHENOTYPE


name: GERBICH BLOOD GROUP SYSTEM, DUCH PHENOTYPE


name: CIP1/WAF1 TUMOR-ASSOCIATED POLYMORPHISM 1


name: CILIARY NEUROTROPHIC FACTOR POLYMORPHISM


name: EPIDERMOLYSIS BULLOSA, PRETIBIAL, AUTOSOMAL RECESSIVE


name: BONE MINERAL DENSITY VARIATION QUANTITATIVE TRAIT LOCUS


name: OSTEOGENESIS IMPERFECTA, TYPE II, THIN-BONE TYPE


name: INTERVERTEBRAL DISC DISEASE, SUSCEPTIBILITY TO


name: COLORECTAL CANCER, SPORADIC, SUSCEPTIBILITY TO


name: MACULAR DEGENERATION, AGE-RELATED, 9, SUSCEPTIBILITY TO


name: C3 POLYMORPHISM, HAV 4-1 PLUS/MINUS TYPE


name: MACULAR DEGENERATION, AGE-RELATED, 15, SUSCEPTIBILITY TO


name: COMPLEMENT COMPONENT 8, ALPHA SUBUNIT, A/B POLYMORPHISM


name: CATARACT 14, NUCLEAR PULVERULENT AND POSTERIOR POLAR


name: CATARACT 9, MULTIPLE TYPES, WITH MICROCORNEA


name: CATARACT 9, TOTAL, WITH MICROCORNEA, AUTOSOMAL RECESSIVE


name: CATARACT 10, CONGENITAL ZONULAR, WITH SUTURAL OPACITIES


name: CATARACT 22, MULTIPLE TYPES, AUTOSOMAL DOMINANT


name: CATARACT 4, NONNUCLEAR POLYMORPHIC CONGENITAL


name: CROMER BLOOD GROUP SYSTEM, Inab PHENOTYPE


name: PALMOPLANTAR KERATODERMA I, STRIATE OR DIFFUSE


name: DNA TOPOISOMERASE I, CAMPTOTHECIN-RESISTANT


name: ATTENTION DEFICIT-HYPERACTIVITY DISORDER, SUSCEPTIBILITY TO


name: DEJERINE-SOTTAS NEUROPATHY, AUTOSOMAL DOMINANT


name: NONSMALL CELL LUNG CANCER, RESPONSE TO TYROSINE KINASE INHIBITOR IN, SOMATIC


name: HYPERCHOLESTEROLEMIA, FAMILIAL, DUE TO LDLR DEFECT, MODIFIER OF


name: ESTROGEN RECEPTOR MUTANT, TEMPERATURE-SENSITIVE


name: XERODERMA PIGMENTOSUM GROUP G/COCKAYNE SYNDROME


name: AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE IA, AUTOSOMAL RECESSIVE


name: SQUAMOUS CELL CARCINOMA, BURN SCAR-RELATED, SOMATIC


name: L-FERRITIN DEFICIENCY, AUTOSOMAL DOMINANT


name: L-FERRITIN DEFICIENCY, AUTOSOMAL RECESSIVE


name: FIBRINOGEN MILANO XII, DIGENIC PHENOTYPE


name: CANCER PROGRESSION AND TUMOR CELL MOTILITY


name: HYPOGONADOTROPIC HYPOGONADISM 2 WITH ANOSMIA, SUSCEPTIBILITY TO


name: HYPOGONADOTROPIC HYPOGONADISM 2 WITH OR WITHOUT ANOSMIA, SUSCEPTIBILITY TO


name: HYPOGONADOTROPIC HYPOGONADISM 2 WITH ANOSMIA


name: HYPOGONADOTROPIC HYPOGONADISM 2 WITHOUT ANOSMIA, SUSCEPTIBILITY TO


name: HYPOGONADOTROPIC HYPOGONADISM 2 WITHOUT ANOSMIA


name: HEMANGIOMA, CAPILLARY INFANTILE, SOMATIC


name: AMYOTROPHIC LATERAL SCLEROSIS 6 WITHOUT FRONTOTEMPORAL DEMENTIA


name: ASPARTATE AMINOTRANSFERASE, REDUCED SERUM LEVEL OF


name: MACULAR DEGENERATION, AGE-RELATED, 14, REDUCED RISK OF


name: HYPOGONADOTROPIC HYPOGONADISM 7 WITHOUT ANOSMIA


name: MCCUNE-ALBRIGHT SYNDROME, SOMATIC, MOSAIC


name: PSEUDOHYPOPARATHYROIDISM, TYPE IA, WITH TESTOTOXICOSIS


name: HAPTOGLOBIN, ALPHA-1, FAST-SLOW POLYMORPHISM


name: FETAL HEMOGLOBIN, A-GAMMA TYPE, REDUCTION IN


name: ANKYLOSING SPONDYLITIS, SUSCEPTIBILITY TO, 1


name: BERYLLIUM DISEASE, CHRONIC, SUSCEPTIBILITY TO


name: IgG RECEPTOR I, PHAGOCYTIC, FAMILIAL DEFICIENCY OF


name: IMMUNOGLOBULIN KAPPA LIGHT CHAIN POLYMORPHISM Inv1


name: IMMUNOGLOBULIN KAPPA LIGHT CHAIN POLYMORPHISM Inv2


name: IMMUNOGLOBULIN KAPPA LIGHT CHAIN POLYMORPHISM Inv3


name: INTER-ALPHA-TRYPSIN INHIBITOR, HEAVY CHAIN 1 POLYMORPHISM


name: INSULIN-LIKE GROWTH FACTOR II POLYMORPHISM


name: ACQUIRED IMMUNODEFICIENCY SYNDROME, RAPID PROGRESSION TO


name: RHEUMATOID ARTHRITIS, SYSTEMIC JUVENILE, SUSCEPTIBILITY TO


name: GASTRIC CANCER SUSCEPTIBILITY AFTER H. PYLORI INFECTION


name: NEPHROTIC SYNDROME, TYPE 5, WITHOUT OCULAR ABNORMALITIES


name: NEPHROTIC SYNDROME, TYPE 5, WITH OCULAR ABNORMALITIES


name: HUTCHINSON-GILFORD PROGERIA SYNDROME, ATYPICAL


name: HUTCHINSON-GILFORD PROGERIA SYNDROME, CHILDHOOD-ONSET


name: SUSCEPTIBILITY TO LEPROSY AND MULTIBACILLARY LEPROSY


name: CATARACT 15, LAMELLAR WITH SUTURAL OPACITIES


name: SKIN/HAIR/EYE PIGMENTATION 2, RED HAIR/FAIR SKIN


name: NEURAL TUBE DEFECTS, FOLATE-SENSITIVE, SUSCEPTIBILITY TO


name: DEJERINE-SOTTAS SYNDROME, AUTOSOMAL DOMINANT


name: CHARCOT-MARIE-TOOTH DISEASE, TYPE 1B, WITH FOCALLY FOLDED MYELIN SHEATHS


name: MYELOFIBROSIS WITH MYELOID METAPLASIA, SOMATIC


name: CARDIOMYOPATHY, HYPERTROPHIC, MIDVENTRICULAR, DIGENIC


name: HYPOGONADOTROPIC HYPOGONADISM 10 WITHOUT ANOSMIA


name: HYPOGONADOTROPIC HYPOGONADISM 11 WITHOUT ANOSMIA


name: GREIG CEPHALOPOLYSYNDACTYLY SYNDROME, SEVERE


name: NOONAN SYNDROME-LIKE DISORDER WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA


name: PAPILLORENAL SYNDROME WITH MILD OCULAR ABNORMALITIES


name: PAPILLORENAL SYNDROME WITH MACULAR ABNORMALITIES


name: DIABETES MELLITUS, KETOSIS-PRONE, SUSCEPTIBILITY TO


name: AMYOTROPHIC LATERAL SCLEROSIS, SUSCEPTIBILITY TO


name: INFLAMMATORY BOWEL DISEASE 13, SUSCEPTIBILITY TO


name: ALKALINE PHOSPHATASE, PLACENTAL, ALLELE-1 POLYMORPHISM


name: ALKALINE PHOSPHATASE, PLACENTAL, ALLELE-3 POLYMORPHISM


name: SPINA BIFIDA, FOLATE-SENSITIVE, SUSCEPTIBILITY TO


name: TRANSCRIPTION OF PLASMINOGEN ACTIVATOR INHIBITOR, MODULATOR OF


name: HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC, RESISTANT TO IMATINIB


name: SPHEROCYTOSIS, TYPE 5, DUE TO PROTEIN 4.2-NIPPON


name: SPHEROCYTOSIS, TYPE 5, DUE TO PROTEIN 4.2-LISBOA


name: SPHEROCYTOSIS, TYPE 5, DUE TO PROTEIN 4.2-TOZEUR


name: SPHEROCYTOSIS, TYPE 5, DUE TO PROTEIN 4.2-NOTAME


name: SPHEROCYTOSIS, TYPE 5, DUE TO PROTEIN 4.2-HAMMERSMITH


name: CATARACT 21, CERULEAN, WITH OR WITHOUT MICROCORNEA


name: APNEA, POSTANESTHETIC, DUE TO BCHE, ATYPICAL-1


name: RETINITIS PUNCTATA ALBESCENS, AUTOSOMAL DOMINANT


name: BREAST CANCER, SUSCEPTIBILITY TO, IN BRCA1 AND BRCA2 CARRIERS


name: RETINITIS PIGMENTOSA 4, AUTOSOMAL RECESSIVE


name: VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1, WITH OR WITHOUT ATRIAL DYSFUNCTION AND DILATED CARDIOMYOPATHY


name: SECRETOR/NONSECRETOR POLYMORPHISM, JAPANESE TYPE


name: OBSESSIVE-COMPULSIVE DISORDER, SUSCEPTIBILITY TO


name: MAJOR DEPRESSIVE DISORDER, RESPONSE TO CITALOPRAM THERAPY IN


name: SEROTONIN TRANSPORTER ACTIVITY, INCREASED/DECREASED


name: FEBRILE SEIZURES, FAMILIAL, 3A, SUSCEPTIBILITY TO


name: SPHEROCYTOSIS, TYPE 3, AUTOSOMAL RECESSIVE


name: HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, DELAYED DISEASE PROGRESSION WITH INFECTION BY


name: HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, RAPID DISEASE PROGRESSION WITH INFECTION BY


name: ACRODYSOSTOSIS 1 WITH HORMONE RESISTANCE


name: ACRODYSOSTOSIS 1 WITHOUT HORMONE RESISTANCE


name: LEUKEMIA, PHILADELPHIA CHROMOSOME-POSITIVE, RESISTANT TO IMATINIB


name: CYSTIC FIBROSIS LUNG DISEASE, MODIFIER OF


name: ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA 1


name: HEMANGIOMA, CAPILLARY INFANTILE, SUSCEPTIBILITY TO


name: HYPERLIPIDEMIA, FAMILIAL COMBINED, SUSCEPTIBILITY TO


name: DIABETES INSIPIDUS, NEUROHYPOPHYSEAL, AUTOSOMAL RECESSIVE


name: MAJOR AFFECTIVE DISORDER 7, SUSCEPTIBILITY TO


name: MACULAR DEGENERATION, AGE-RELATED, 13, SUSCEPTIBILITY TO


name: MENKES DISEASE, COPPER-REPLACEMENT RESPONSIVE


name: HETEROTOPIA, PERIVENTRICULAR NODULAR, X-LINKED, WITH FRONTOMETAPHYSEAL DYSPLASIA


name: ALPHA-THALASSEMIA MYELODYSPLASIA SYNDROME, SOMATIC


name: NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2A, SEVERE


name: CHONDRODYSPLASIA PUNCTATA 2, X-LINKED DOMINANT, ATYPICAL


name: AMYOTROPHIC LATERAL SCLEROSIS 15 WITH FRONTOTEMPORAL DEMENTIA


name: AMELOGENESIS IMPERFECTA, TYPE 1E, WITH SNOW-CAPPED TEETH


name: GRANULOMATOUS DISEASE, CHRONIC, X-LINKED, SOMATIC MOSAIC


name: HYPOGONADOTROPIC HYPOGONADISM 1 WITH ANOSMIA


name: THROMBOCYTOPENIA, X-LINKED, WITH DYSERYTHROPOIETIC ANEMIA


name: THROMBOCYTOPENIA, X-LINKED, WITHOUT DYSERYTHROPOIETIC ANEMIA


name: PHOSPHOGLYCERATE KINASE 1 DEFICIENCY, MUNCHEN


name: PHOSPHOGLYCERATE KINASE 1 DEFICIENCY, UPPSALA


name: PHOSPHOGLYCERATE KINASE 1 DEFICIENCY, TOKYO


name: PHOSPHOGLYCERATE KINASE 1 DEFICIENCY, MATSUE


name: PHOSPHOGLYCERATE KINASE 1 DEFICIENCY, SHIZUOKA


name: PHOSPHOGLYCERATE KINASE 1 DEFICIENCY, MICHIGAN


name: PHOSPHOGLYCERATE KINASE 1 DEFICIENCY, ALABAMA


name: PHOSPHOGLYCERATE KINASE 1 DEFICIENCY, HAMAMATSU


name: PHOSPHOGLYCERATE KINASE 1 DEFICIENCY, HERLEV


name: PHOSPHOGLYCERATE KINASE 1 DEFICIENCY, BARCELONA


name: PHOSPHOGLYCERATE KINASE 1 DEFICIENCY, MURCIA


name: PHOSPHOGLYCERATE KINASE 1 DEFICIENCY, AMIENS


name: PHOSPHOGLYCERATE KINASE 1 DEFICIENCY, FUKUROI


name: PHOSPHOGLYCERATE KINASE 1 DEFICIENCY, AFULA


name: ARTS SYNDROME AND PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY


name: ANDROGEN INSENSITIVITY, PARTIAL, WITH BREAST CANCER


name: CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIm, SOMATIC MOSAIC


name: EXERCISE INTOLERANCE, CARDIOMYOPATHY, AND SEPTOOPTIC DYSPLASIA


name: MYOPATHY, MITOCHONDRIAL, WITH DIABETES MELLITUS


name: CARDIOMYOPATHY, IDIOPATHIC DILATED, MITOCHONDRIAL


name: PIGMENTARY RETINOPATHY AND SENSORINEURAL DEAFNESS


name: ENCEPHALOPATHY, FAMILIAL PROGRESSIVE NECROTIZING


name: PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA, PROXIMAL MYOPATHY, AND SUDDEN DEATH


name: NEUROPSYCHIATRIC DISORDER AND EARLY-ONSET CATARACT


name: PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MYOCLONUS


name: MITOCHONDRIAL CYTOCHROME c OXIDASE DEFICIENCY


name: EXERCISE INTOLERANCE, MUSCLE PAIN, AND LACTIC ACIDEMIA


name: CEREBELLAR ATAXIA, CATARACT, AND DIABETES MELLITUS


name: EXERCISE INTOLERANCE AND COMPLEX III DEFICIENCY, SOMATIC


name: CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MYOPATHY, SOMATIC


name: FOCAL SEGMENTAL GLOMERULOSCLEROSIS AND DILATED CARDIOMYOPATHY


name: ATAXIA, PROGRESSIVE SEIZURES, MENTAL DETERIORATION, AND HEARING LOSS


name: LEUKEMIA, T-CELL ACUTE LYMPHOBLASTIC, SOMATIC


name: METAPHYSEAL ANADYSPLASIA 1, AUTOSOMAL DOMINANT


name: ACRODYSOSTOSIS 2 WITH HORMONE RESISTANCE


name: ACRODYSOSTOSIS 2 WITHOUT HORMONE RESISTANCE


name: MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO , 2


name: METAPHYSEAL DYSPLASIA AND MAXILLARY HYPOPLASIA WITH OR WITHOUT BRACHYDACTYLY


name: EPIPHYSEAL DYSPLASIA, MULTIPLE, 1, SEVERE


name: ATAXIA, FRIEDREICH-LIKE, WITH ISOLATED VITAMIN E DEFICIENCY


name: HYPOGONADOTROPIC HYPOGONADISM 6 WITHOUT ANOSMIA


name: HYPOGONADOTROPIC HYPOGONADISM 6 WITH ANOSMIA


name: ATRIAL SEPTAL DEFECT 7 WITH ATRIOVENTRICULAR CONDUCTION DEFECTS


name: ATRIAL SEPTAL DEFECT 7 WITH OR WITHOUT ATRIOVENTRICULAR CONDUCTION DEFECTS, SOMATIC


name: ATRIAL SEPTAL DEFECT 7 WITHOUT ATRIOVENTRICULAR CONDUCTION DEFECTS


name: CHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM WITH PULMONARY DYSFUNCTION


name: MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY, AUTOSOMAL RECESSIVE


name: MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY, AUTOSOMAL DOMINANT


name: PULMONARY FIBROSIS, IDIOPATHIC, SUSCEPTIBILITY TO


name: XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP E, DDB-NEGATIVE FORM


name: CATARACT 1, POSTERIOR SUBCAPSULAR, WITH MICROCORNEA


name: CATARACT 1, STELLATE NUCLEAR, WITH MICROCORNEA


name: IMMUNODEFICIENCY 26 WITHOUT NEUROLOGIC ABNORMALITIES


name: IMMUNODEFICIENCY 26 WITH NEUROLOGIC ABNORMALITIES


name: CATARACT 17, CONGENITAL NUCLEAR, AUTOSOMAL RECESSIVE


name: LARON SYNDROME WITH ELEVATED SERUM GH-BINDING PROTEIN


name: LARON SYNDROME WITH UNDETECTABLE SERUM GH-BINDING PROTEIN


name: HYPERCHOLESTEROLEMIA, FAMILIAL, MODIFIER OF


name: HYPERTENSION, EARLY-ONSET, AUTOSOMAL DOMINANT, WITH EXACERBATION IN PREGNANCY


name: PROSTATE CANCER, PROGRESSION AND METASTASIS OF, SOMATIC


name: PROSTATE CANCER, SUSCEPTIBILITY TO, IN AFRICAN AMERICANS, SOMATIC


name: CHARCOT-MARIE-TOOTH DISEASE, TYPE 1A, AUTOSOMAL RECESSIVE


name: CHARCOT-MARIE-TOOTH DISEASE, TYPE 1A, WITH FOCALLY FOLDED MYELIN SHEATHS


name: RIPPLING MUSCLE DISEASE 2, AUTOSOMAL RECESSIVE


name: ACQUIRED IMMUNODEFICIENCY SYNDROME, DELAYED PROGRESSION TO


name: HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, RAPID PROGRESSION TO AIDS


name: FACTOR V AND FACTOR VIII, COMBINED DEFICIENCY OF, 1, MIDDLE EASTERN JEWISH TYPE


name: FACTOR V AND FACTOR VIII, COMBINED DEFICIENCY OF, 1, SEPHARDIC JEWISH TYPE


name: FUNDUS ALBIPUNCTATUS, AUTOSOMAL RECESSIVE


name: PEROXISOMAL BIOGENESIS DISORDER 3A (ZELLWEGER)


name: UCP3 POLYMORPHISM, EXON 6 SPLICE DONOR JUNCTION


name: NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IIB, AUTOSOMAL RECESSIVE


name: WAARDENBURG SYNDROME, TYPE 2E, WITHOUT NEUROLOGIC INVOLVEMENT


name: EPILEPSY, PROGRESSIVE MYOCLONIC, 4, WITH RENAL FAILURE


name: EPILEPSY, PROGRESSIVE MYOCLONIC, 4, WITHOUT RENAL FAILURE


name: SWEAT CHLORIDE ELEVATION WITHOUT CYSTIC FIBROSIS


name: PANCREATITIS, IDIOPATHIC, SUSCEPTIBILITY TO


name: DEAFNESS, NEUROSENSORY AUTOSOMAL RECESSIVE 21


name: MAJOR DEPRESSIVE DISORDER, INCREASED RECURRENCE OF DEPRESSIVE EPISODES IN, SUSCEPTIBILITY TO


name: HYPOGONADOTROPIC HYPOGONADISM 19 WITH ANOSMIA


name: HYPOGONADOTROPIC HYPOGONADISM 19 WITH ANOSMIA, SUSCEPTIBILITY TO


name: HYPOGONADOTROPIC HYPOGONADISM 19 WITHOUT ANOSMIA


name: SPASTIC PARAPLEGIA 10 WITH PERIPHERAL NEUROPATHY


name: RETINAL ARTERIAL MACROANEURYSM WITH SUPRAVASCULAR PULMONIC STENOSIS


name: SHORT-RIB THORACIC DYSPLASIA 3 WITHOUT POLYDACTYLY


name: SHORT-RIB THORACIC DYSPLASIA 3 WITH POLYDACTYLY


name: SHORT-RIB THORACIC DYSPLASIA 3/6 WITH POLYDACTYLY, DIGENIC


name: CILIARY DYSKINESIA, PRIMARY, 28, WITHOUT SITUS INVERSUS


name: CILIARY DYSKINESIA, PRIMARY, 28, WITH SITUS INVERSUS


name: EXUDATIVE VITREORETINOPATHY 4, AUTOSOMAL DOMINANT


name: EXUDATIVE VITREORETINOPATHY 4, AUTOSOMAL RECESSIVE


name: BJORNSTAD SYNDROME WITH MILD MITOCHONDRIAL COMPLEX III DEFICIENCY


name: AUDITORY NEUROPATHY, AUTOSOMAL RECESSIVE, 1, TEMPERATURE-SENSITIVE


name: HYPOGONADOTROPIC HYPOGONADISM 20 WITH ANOSMIA, SUSCEPTIBILITY TO


name: HYPOGONADOTROPIC HYPOGONADISM 20 WITHOUT ANOSMIA


name: HYPOGONADOTROPIC HYPOGONADISM 20 WITH ANOSMIA


name: MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC TYPE WITH METHYLMALONIC ACIDURIA)


name: MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC TYPE WITHOUT METHYLMALONIC ACIDURIA)


name: HYPOGONADOTROPIC HYPOGONADISM 16 WITH ANOSMIA, SUSCEPTIBILITY TO


name: HYPOGONADOTROPIC HYPOGONADISM 8 WITHOUT ANOSMIA


name: HYPOGONADOTROPIC HYPOGONADISM 8 WITH ANOSMIA, SUSCEPTIBILITY TO


name: ESOPHAGEAL SQUAMOUS CELL CARCINOMA, SOMATIC


name: SHORT-RIB THORACIC DYSPLASIA 6 WITH POLYDACTYLY


name: SHORT-RIB THORACIC DYSPLASIA 6 WITHOUT POLYDACTYLY


name: CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE 1B


name: NEPHROTIC SYNDROME, TYPE 2, SUSCEPTIBILITY TO


name: HYPOGONADOTROPIC HYPOGONADISM 21 WITH ANOSMIA, SUSCEPTIBILITY TO


name: HYPOGONADOTROPIC HYPOGONADISM 21 WITH ANOSMIA


name: HYPOGONADOTROPIC HYPOGONADISM 15 WITH OR WITHOUT ANOSMIA, SUSCEPTIBILITY TO


name: HYPOGONADOTROPIC HYPOGONADISM 15 WITH ANOSMIA, SUSCEPTIBILITY TO


name: AMYOTROPHIC LATERAL SCLEROSIS 10 WITHOUT FRONTOTEMPORAL DEMENTIA AND WITH TDP43 INCLUSIONS


name: AMYOTROPHIC LATERAL SCLEROSIS 10 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA AND WITH TDP43 INCLUSIONS


name: CONGENITAL HEART DISEASE, MULTIPLE TYPES, 2


name: HYPERCALCIURIA, ABSORPTIVE, SUSCEPTIBILITY TO


name: LANGEREIS BLOOD GROUP SYSTEM, LAN(-) PHENOTYPE


name: MYOGLOBINURIA, RECURRENT, AUTOSOMAL RECESSIVE


name: CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIf, MODIFIER OF


name: AMYOTROPHIC LATERAL SCLEROSIS-PARKINSONISM/DEMENTIA COMPLEX 1, SUSCEPTIBILITY TO


name: NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IC, SEVERE


name: DEJERINE-SOTTAS NEUROPATHY, AUTOSOMAL RECESSIVE


name: PSEUDOHYPOALDOSTERONISM, TYPE IID, AUTOSOMAL RECESSIVE


name: PSEUDOHYPOALDOSTERONISM, TYPE IID, AUTOSOMAL DOMINANT OR RECESSIVE


name: PSEUDOHYPOALDOSTERONISM, TYPE IID, AUTOSOMAL DOMINANT


name: HIRSCHSPRUNG DISEASE-MENTAL RETARDATION SYNDROME, LATE INFANTILE


name: PLASMA TRIGLYCERIDE LEVEL QUANTITATIVE TRAIT LOCUS, LOW


name: ENCEPHALOPATHY, PROGRESSIVE, WITH LIPODYSTROPHY


name: TYPE 2 DIABETES MELLITUS, ASSOCIATION WITH


name: GOITER, MULTINODULAR 1, WITHOUT SERTOLI-LEYDIG CELL TUMORS


name: HYPOGONADOTROPIC HYPOGONADISM 14 WITHOUT ANOSMIA


name: HYPOGONADOTROPIC HYPOGONADISM 14 WITH ANOSMIA


name: NEUROPATHY, AXONAL, WITH VOCAL CORD PARESIS, AUTOSOMAL RECESSIVE


name: CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL DOMINANT, TYPE 2K


name: HYPOGONADOTROPIC HYPOGONADISM 18 WITH ANOSMIA


name: HYPOGONADOTROPIC HYPOGONADISM 18 WITH ANOSMIA, SUSCEPTIBILITY TO


name: COMPLEMENT COMPONENT 4, PARTIAL DEFICIENCY OF, DUE TO DYSFUNCTIONAL C1 INHIBITOR


name: CHEDIAK-HIGASHI SYNDROME, CHILDHOOD TYPE


name: HYPOGONADOTROPIC HYPOGONADISM 4 WITH ANOSMIA


name: CEROID LIPOFUSCINOSIS, NEURONAL, 3, PROTRACTED


name: FOVEAL HYPOPLASIA 1 WITH ANTERIOR SEGMENT ANOMALIES


name: HYPOGONADOTROPIC HYPOGONADISM 3 WITH ANOSMIA


name: HYPOGONADOTROPIC HYPOGONADISM 3 WITHOUT ANOSMIA


name: INFLAMMATORY BOWEL DISEASE 14, SUSCEPTIBILITY TO


name: SYSTEMIC LUPUS ERYTHEMATOSUS, ASSOCIATION WITH SUSCEPTIBILITY TO, 10


name: AUTOIMMUNE POLYENDOCRINOPATHY SYNDROME, TYPE I


name: SHORT-RIB THORACIC DYSPLASIA 10 WITHOUT POLYDACTYLY


name: SHORT-RIB THORACIC DYSPLASIA 10 WITH POLYDACTYLY


name: INFLAMMATORY BOWEL DISEASE 17, PROTECTION AGAINST


name: ARYLSULFATASE A PSEUDODEFICIENCY, SEVERE


name: ARYLSULFATASE A PSEUDODEFICIENCY, INTERMEDIATE


name: ATAXIA-TELANGIECTASIA, COMPLEMENTATION GROUP A


name: ATAXIA-TELANGIECTASIA, COMPLEMENTATION GROUP E


name: ATAXIA-TELANGIECTASIA, COMPLEMENTATION GROUP D


name: NIEMANN-PICK DISEASE, TYPE C1, ADULT FORM


name: NIEMANN-PICK DISEASE, TYPE C1, JUVENILE FORM


name: GLYCOGEN STORAGE DISEASE IV, CONGENITAL NEUROMUSCULAR


name: GLYCOGEN STORAGE DISEASE IV, NONPROGRESSIVE HEPATIC


name: GLYCOGEN STORAGE DISEASE IV, CLASSIC HEPATIC


name: GLYCOGEN STORAGE DISEASE IV, COMBINED HEPATIC AND MYOPATHIC


name: JOHN MILTON HAGEN BLOOD GROUP SYSTEM, JMH-VARIANT PHENOTYPE


name: HYPOGONADOTROPIC HYPOGONADISM 17 WITH ANOSMIA


name: HYPOGONADOTROPIC HYPOGONADISM 17 WITH OR WITHOUT ANOSMIA, SUSCEPTIBILITY TO


name: HYPOGONADOTROPIC HYPOGONADISM 17 WITHOUT ANOSMIA


name: APOLIPOPROTEIN C-II (ST. MICHAEL) PHENOTYPE


name: APOLIPOPROTEIN C-II (NIJMEGEN) PHENOTYPE


name: apolipoprotein C-II (Wakayama) phenotype


name: APOLIPOPROTEIN C-II (AUCKLAND) PHENOTYPE


name: HYPOGONADOTROPIC HYPOGONADISM 9 WITHOUT ANOSMIA, SUSCEPTIBILITY TO


name: HYPOGONADOTROPIC HYPOGONADISM 9 WITH ANOSMIA, SUSCEPTIBILITY TO


name: RENAL CELL CARCINOMA WITH PARANEOPLASTIC ERYTHROCYTOSIS


name: MACULAR DEGENERATION, AGE-RELATED, 1, SUSCEPTIBILITY TO


name: OCCULT MACULAR DYSTROPHY, SUSCEPTIBILITY TO


name: PYRUVATE HYDROGENASE E3-BINDING PROTEIN DEFICIENCY


name: SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY, DELAYED ONSET


name: SCIANNA BLOOD GROUP SYSTEM, SC:-1,-2 PHENOTYPE


name: SCIANNA BLOOD GROUP SYSTEM, SC:-1,2 PHENOTYPE


name: SCIANNA BLOOD GROUP SYSTEM, STAR ANTIGEN PHENOTYPE


name: PSEUDOFOLLICULITIS BARBAE, SUSCEPTIBILITY TO


name: 17-@ALPHA-HYDROXYLASE/17,20-LYASE DEFICIENCY, COMBINED COMPLETE


name: INTRINSIC FACTOR DEFICIENCY, CONGENITAL, SUSCEPTIBILITY TO


name: MACULAR DEGENERATION, AGE-RELATED, 5, SUSCEPTIBILITY TO


name: PAROXYSMAL NOCTURNAL HEMOGLOBINURIA 2, SUSCEPTIBILITY TO


name: POLYGLUCOSAN BODY MYOPATHY 1 WITH IMMUNODEFICIENCY


name: POLYGLUCOSAN BODY MYOPATHY 1 WITHOUT IMMUNODEFICIENCY


name: POLYGLUCOSAN BODY MYOPATHY WITHOUT IMMUNODEFICIENCY


name: RETINITIS PIGMENTOSA IN CILIOPATHIES, MODIFIER OF


name: LEUKOENCEPHALOPATHY WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LACTATE ELEVATION, MILD


name: MYOPATHY, CENTRONUCLEAR, AUTOSOMAL DOMINANT, MODIFIER OF


name: TYPE 2 DIABETES MELLITUS, PROTECTION AGAINST


name: SHORT-RIB THORACIC DYSPLASIA 2 WITH POLYDACTYLY


name: SHORT-RIB THORACIC DYSPLASIA 2 WITHOUT POLYDACTYLY


name: DEHYDRATED HEREDITARY STOMATOCYTOSIS AND PSEUDOHYPERKALEMIA


name: DEHYDRATED HEREDITARY STOMATOCYTOSIS WITH PSEUDOHYPERKALEMIA AND PERINATAL EDEMA


name: MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 2, SOMATIC


name: MACULAR DEGENERATION, AGE-RELATED, 8, SUSCEPTIBILITY TO


name: MUCOPOLYSACCHARIDOSIS, TYPE VI, INTERMEDIATE


name: SPERMATOGENIC FAILURE 10, SUSCEPTIBILITY TO


name: EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITHOUT INTRACELLULAR INCLUSIONS


name: EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITH INTRACELLULAR INCLUSIONS


name: FAMILIAL ADENOMATOUS POLYPOSIS 1, ATTENUATED


name: FAMILIAL ADENOMATOUS POLYPOSIS 1, SUSCEPTIBILITY TO


name: PALMOPLANTAR KERATODERMA, FOCAL OR DIFFUSE


name: SPHEROCYTOSIS, TYPE 1, DUE TO ANKYRIN-RAKOVNIK


name: SPHEROCYTOSIS, TYPE 1, AUTOSOMAL RECESSIVE


name: SPHEROCYTOSIS, TYPE 1, DUE TO ANKYRIN SAINT-ETIENNE 1


name: SPHEROCYTOSIS, TYPE 1, DUE TO ANKYRIN SAINT-ETIENNE 2


name: SPHEROCYTOSIS, TYPE 1, DUE TO ANKYRIN FLORIANOPOLIS


name: HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A, DUE TO PARTIAL PTS DEFICIENCY


name: LUTHERAN BLOOD GROUP POLYMORPHISM Lu(a)/Lu(b)


name: AUBERGER BLOOD GROUP POLYMORPHISM Au(a)/Au(b)


name: RETINAL DISEASE IN USHER SYNDROME TYPE IIA, MODIFIER OF


name: VON WILLEBRAND DISEASE, TYPE 1, SUSCEPTIBILITY TO


name: HYPOGONADOTROPIC HYPOGONADISM 22 WITH ANOSMIA


name: GYRATE ATROPHY OF CHOROID AND RETINA WITH PYRIDOXINE-RESPONSIVE ORNITHINEMIA


name: BROWN-VIALETTO-VAN LAERE SYNDROME 1, MILD


name: SHORT-RIB THORACIC DYSPLASIA 11 WITHOUT POLYDACTYLY


name: MICROCEPHALY 2, PRIMARY, AUTOSOMAL RECESSIVE, WITH CORTICAL MALFORMATIONS


name: SHORT-RIB THORACIC DYSPLASIA 7 WITH POLYDACTYLY


name: DUFFY BLOOD GROUP SYSTEM, FYA/FYB POLYMORPHISM


name: DUFFY BLOOD GROUP SYSTEM, FY(a-b-) PHENOTYPE


name: DUFFY BLOOD GROUP SYSTEM, FY(bwk) PHENOTYPE


name: TREACHER COLLINS SYNDROME 2, AUTOSOMAL RECESSIVE


name: ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY, LATE-ONSET FORM


name: MYOCARDIAL INFARCTION, DECREASED SUSCEPTIBILITY TO


name: LW BLOOD GROUP SYSTEM, LW(a)/LW(b) POLYMORPHISM


name: LW BLOOD GROUP SYSTEM, LW(a-b-) PHENOTYPE


name: LEUKODYSTROPHY, HYPOMYELINATING, 7, WITH OLIGODONTIA AND HYPOGONADOTROPIC HYPOGONADISM


name: LEUKODYSTROPHY, HYPOMYELINATING, 7, WITHOUT OLIGODONTIA OR HYPOGONADOTROPIC HYPOGONADISM


name: LEUKODYSTROPHY, HYPOMYELINATING, 8, WITHOUT HYPODONTIA AND WITH HYPOGONADOTROPIC HYPOGONADISM


name: LEUKODYSTROPHY, HYPOMYELINATING, 8, WITHOUT HYPODONTIA OR HYPOGONADOTROPIC HYPOGONADISM


name: LEUKODYSTROPHY, HYPOMYELINATING, 8, WITH HYPODONTIA AND HYPOGONADOTROPIC HYPOGONADISM


name: VEL BLOOD GROUP SYSTEM, VEL-NULL PHENOTYPE


name: SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 1, WITH FRACTURES


name: SHORT-RIB THORACIC DYSPLASIA 8 WITH POLYDACTYLY


name: CILIARY DYSKINESIA, PRIMARY, 26, WITH SITUS INVERSUS


name: CILIARY DYSKINESIA, PRIMARY, 26, WITHOUT SITUS INVERSUS


name: FOVEAL HYPOPLASIA 2 WITH OR WITHOUT MICROPHTHALMIA OR COLOBOMA


name: FOVEAL HYPOPLASIA 2 AND OPTIC NERVE MISROUTING WITH OR WITHOUT ANTERIOR SEGMENT DYSGENESIS


name: HIGH DENSITY LIPOPROTEIN DEFICIENCY, DETROIT TYPE


name: HEMOGLOBIN SAN FRANCISCO (PACIFIC) PHENOTYPE


name: HEMOGLOBIN NORTH SHORE-CARACAS PHENOTYPE


name: HEMOGLOBIN LEPORE (WASHINGTON) PHENOTYPE


name: NADH-DEHYDROGENASE SUBUNIT 1, MITOCHONDRIAL, MUTATION IN


name: MITOCHONDRIAL COMPLEX IV DEFICIENCY WITH RECURRENT MYOGLOBINURIA


name: DIABETES MELLITUS, NONINSULIN-DEPENDENT, MATERNALLY TRANSMITTED


name: BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 1, MODIFIER OF


name: CARDIOMYOPATHY, DILATED, 1BB, SUSCEPTIBILITY TO


name: ALDOSTERONE-PRODUCING ADRENAL ADENOMA, SOMATIC


name: FOVEAL HYPOPLASIA 1 WITH OR WITHOUT ANTERIOR SEGMENT ANOMALIES


name: Leukonychia, more pronounced on fingernails than toenails


name: CATARACT 22, NUCLEAR, AUTOSOMAL RECESSIVE


name: Lymphoid nodules on respiratory mucosal surfaces


name: Muscle wasting, severe, primarily in the legs


name: Loss of anterior horn cells and gliosis in the spinal cord


name: Low or absent thyroid-stimulating hormone


name: DEAFNESS, AUTOSOMAL RECESSIVE 36, WITH VESTIBULAR INVOLVEMENT


name: No atrial electrical activity on endocavitary recordings


name: EGLN1, ASP4GLU AND CYS127SER (dbSNP rs186996510 AND dbSNP rs12097901)


name: MICROVASCULAR COMPLICATIONS OF DIABETES, PROTECTION AGAINST


name: Severely reduced rod responses on electroretinography


name: HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, INCREASED PERINATAL TRANSMISSION OF


name: Increased variability in length of body hair


name: {7 (vilazodone hydrochloride 10 MG Oral Tablet [Viibryd]) / 23 (vilazodone hydrochloride 20 MG Oral Tablet [Viibryd]) } Pack [Viibryd Starter Pack 10/20 30 Day Pack]


name: BRIEF,DERMADRY BARIATRIC XX-LARGE ATTENDS


name: CATHETER,CLEAN-CATH VINYL 14FR BARD#420614


name: CATHETER,EXTERNAL SILICONE COLOPLAST #6100


name: CATHETER,EXTERNAL SILICONE COLOPLAST #6130


name: CATHETER,FOLEY COUDE 22FR 30ML BARD #0103L22


name: CATHETER,SELF-CATH CLOSED SYSTEM 14FR COLOPLAST #3614


name: DRESSING,ACTISORB SILVER 4 1/8IN X 4 1/8IN


name: GAUZE,PACKING ALGINATE AG 0.25IN X 5YD DEROYAL #46-PG14


name: GAUZE,PACKING ALGINATE AG 0.5IN X 5YD DEROYAL #46-PG12


name: PLEURAL DRAINAGE BOTTLE 600ML BRAUN #622272


name: POUCH,DRAINABLE,PREMIER HIGH OUTPUT H#81070


name: POUCH,DRAINABLE,PREMIER HIGH OUTPUT H#81110


name: TRACH TUBE,SZ 7 BIVONA TTS SMITHS #670170


name: Medical Food Oral Liquid [Pro-Stat Sugar Free]


name: Nutritional Supplement Oral Powder for Suspension [Beneprotein]


name: ZINC OXIDE 10 g in 17.5 mL / OCTINOXATE 7.5 g in 17.5 mL TOPICAL CREAM [Sunscreen Broad Spectrum SPF 50 Vitality Institute]


name: Gel, Multi Ingredient Topical application Gel/Jelly [Recedo]


name: Similac Go & Grow Sensitive Stage 3 Powder


name: Bordetella pertussis filamentous hemagglutinin vaccine, inactivated / Bordetella pertussis fimbriae 2/3 vaccine, inactivated / Bordetella pertussis pertactin vaccine, inactivated / Bordetella pertussis toxoid vaccine, inactivated / diphtheria toxoid vaccine, inactivated / poliovirus vaccine inactivated, type 1 (Mahoney) / poliovirus vaccine inactivated, type 2 (MEF-1) / poliovirus vaccine inactivated, type 3 (Saukett) / tetanus toxoid vaccine, inactivated


name: Comfort Assist 1/2ML 29G 1/2 inch Insulin Syringe


name: Comfort Assist 1ML 29G 1/2 inch Insulin Syringe


name: Comfort Assist 3/10ML 29G 1/2 inch Insulin Syringe


name: Comfort Assist Short Needle 1/2ML 30G 5/16 inch Insulin Syringe


name: Comfort Assist Short Needle 1/2ML 31G 5/16 inch Insulin Syringe


name: Comfort Assist Short Needle 1ML 30G 5/16 inch Insulin Syringe


name: Comfort Assist Short Needle 1ML 31G 5/16 inch Insulin Syringe


name: Comfort Assist Short Needle 3/10ML 30G 5/16 inch Insulin Syringe


name: Comfort Assist Short Needle 3/10ML 31G 5/16 inch Insulin Syringe


name: hexamethylene diisocyanate-trimethylol hexyllactone crosspolymer


name: TITANIUM DIOXIDE 12.1 mg in 100 mL TOPICAL CREAM [BROAD SPECTRUM SUNSCREEN SPF 30]


name: CAPSULE,ORAL ONLY, EXTENDED RELEASE 12HR


name: colostomy bag, non-sterile 2 3/8" (8") MISCELL EACH


name: honey/hydrocolloid dressing 2" X 2" TOPICAL BANDAGE


name: honey/hydrocolloid dressing 4" X 5" TOPICAL BANDAGE


name: Lenvima 30 Day Supply includes 14, 18 & 24 MG Daily Dose Packs


name: nutritional therapy, impaired renal function 0.03 gram-2 kcal/mL ORAL LIQUID (ML)


name: Activated Charcoal/Silver 100 GM-220 MG Topical application Dressing [Actisorb Silver 220]


name: Activated Charcoal/Silver 100 GM-220 MG Topical application Dressing


name: Cellulose Acetate/Silicone Topical application Dressing


name: Cellulose Acetate/Silicone Topical application Dressing [Adaptic Touch]


name: Petrolatum Topical application Dressing [Adaptic Non-Adhering Dressing]


name: procarbazine HCl 100 % MISCELL POWDER (GRAM)


name: OCTOCRYLENE 100 mg in 1 mL / OCTINOXATE 75 mg in 1 mL / HOMOSALATE 75 mg in 1 mL / OCTISALATE 50 mg in 1 mL / AVOBENZONE 30 mg in 1 mL TOPICAL SPRAY [Kinesys Broad Spectrum SPF 50 Alcohol Free Sunscreen]


name: Alginic Acid/Carboxymethylcellulose/Silver Topical application Dressing


name: Alginic Acid/Carboxymethylcellulose/Silver Topical application Dressing [Silvercel Non-Adherent]


name: Calcium Alginate/Collagen 10%-90% Topical application Dressing


name: Calcium Alginate/Collagen 10%-90% Topical application Dressing [Fibracol Plus]


name: sodium/potassium/chloride/citrate/Zn asp/magnesium/carb supp 305 mg-175 mg-70 mg-2.5 gram-2 mg-40 mg-9 gram ORAL POWDER IN PACKET (EA)


name: sodium/potassium/chloride/citrate/Zn asp/magnesium/carb supp 320 mg-190 mg-70 mg-2.5 gram-1.2 mg-40 mg-8 gram ORAL POWDER IN PACKET (EA)


name: sodium/potassium/chloride/citrate/Zn asp/magnesium/carb supp 670 mg-380 mg-150 mg-5 gram-5 mg-80 mg-19 gram ORAL POWDER IN PACKET (EA)


name: sodium/potassium/chloride/citrate/Zn asp/magnesium/carb supp 700 mg-410 mg-150 mg-6 gram-3 mg-90 mg-17 gram ORAL POWDER IN PACKET (EA)


name: EUTREMA JAPONICUM WHOLE 0.1 in 5 mL TOPICAL LIQUID [Wasabia Secret Perfume - Shamar]


name: Bispecific CD19-directed CD3-directed T Cell Engager


name: CISAPRIDE MONOHYDRATE 1 g in 1 g NOT APPLICABLE POWDER


name: Biotin/Cholecalciferol/Copper/Cyanocobalamin/Folic Acid/Heme Iron Polypeptide, Bovine/Iodine/Iron Polysaccharide/Niacin/Pantothenic Acid/Pyridoxine/Riboflavin/Selenium/Thiamine/Vitamin E/Zinc;Docosahexaenoic Acid 30 MCG-400 IU-0.8 MG-12 MCG-1 MG-6 MG-250 MCG-28 MG-17 MG-10 MG-50 MG-1.6 MG-65 MCG-1.5 MG-10 IU-4.5 MG; 200 MG Oral Kit


name: Chloride/Potassium/Sodium 8.3 MEQ/9 GM-4.7 MEQ/9 GM-10.6 MEQ/9 GM Oral Powder for Solution


name: Chloride/Potassium/Sodium 8.3 MEQ/9 GM-4.7 MEQ/9 GM-10.6 MEQ/9 GM Oral Powder for Solution [Pedialyte]


name: AVOBENZONE 28 mg in 1 g / HOMOSALATE 95 mg in 1 g / OCTINOXATE 75 mg in 1 g / OCTOCRYLENE 25.6 mg in 1 g / OXYBENZONE 47.5 mg in 1 g TOPICAL LOTION [Anew Men Daily Moisturizer]


name: OCTINOXATE 75 mg in 1 g TOPICAL LIPSTICK [Beyond Color Lip Conditioner]


name: chlorhexidine / hydrocortisone / ketoconazole


name: {1 (acetaminophen 325 MG / dextromethorphan hydrobromide 10 MG / doxylamine succinate 6.25 MG Oral Capsule) / 1 (acetaminophen 325 MG / dextromethorphan hydrobromide 10 MG / phenylephrine hydrochloride 5 MG Oral Capsule) } Pack


name: Glycerin;Lidocaine Hydrochloride 2% Multiple Routes Kit [DyNAmic Kit]


name: thyroid stimulating immunoglobulins actual/normal in serum


name: Diagnosis present on admission:Find:Pt:^Patient:Ord


name: PROMIS short form - emotional distress - depression 4a - version 1.0:-:Pt:^Patient:-:PROMIS


name: Physical therapy location registry ID:ID:Pt:Facility:Nom


name: Surgical history relevant to physical therapy treatment


name: Surgical history relevant to physical therapy treatment:Type:Pt:^Patient:Nom


name: R wave amplitude.V5+S wave amplitude.V1:Elpot:Pt:Heart:Qn:EKG


name: PROMIS short form - sleep disturbance 6a - version 1.0


name: PROMIS short form - sleep disturbance 6a - version 1.0:-:1W:^Patient:-:PROMIS


name: PROMIS short form - satisfaction with participation in social roles 4a - version 1.0


name: PROMIS short form - satisfaction with participation in social roles 4a - version 1.0:-:1W:^Patient:-:PROMIS


name: PROMIS short form - physical function 8b - version 1.2


name: PROMIS short form - physical function 8b - version 1.2:-:Pt:^Patient:-:PROMIS


name: PROMIS item bank - alcohol - negative consequences - version 1.0


name: PROMIS item bank - alcohol - negative consequences - version 1.0:-:Pt:^Patient:-:PROMIS


name: Deprecated PROMIS pediatric physical function: mobility - version 1.0 Tscore


name: PROMIS pediatric physical function - mobility - version 1.0 T-score:Tscore:Pt:^Patient:Qn:PROMIS.PEDS


name: Brief Pain Inventory short form - pain interference panel


name: Brief Pain Inventory short form - pain interference panel:-:24H:^Patient:-


name: PROMIS short form - emotional support 4a - version 2.0 raw score


name: PROMIS short form - emotional support 4a - version 2.0 raw score:Score:Pt:^Patient:Qn:PROMIS


name: PROMIS short form - satisfaction with social roles and activities 8a - version 2.0 raw score


name: PROMIS short form - satisfaction with social roles and activities 8a - version 2.0 raw score:Score:Pt:^Patient:Qn:PROMIS


name: PROMIS short form - satisfaction with social roles and activities 4a - version 2.0 raw score


name: PROMIS short form - satisfaction with social roles and activities 4a - version 2.0 raw score:Score:Pt:^Patient:Qn:PROMIS


name: PROMIS short form - satisfaction with participation in social roles 4a - version 1.0 raw score


name: Fetal chromosome 18 trisomy:PrThr:Pt:Plas.cfDNA:Ord:Sequencing


name: Fetal chromosome 21 trisomy:PrThr:Pt:Plas.cfDNA:Ord:Sequencing


name: PROMIS short form - social isolation 8a - version 2.0 raw score:Score:Pt:^Patient:Qn:PROMIS


name: PROMIS short form - social isolation 8a - version 2.0:-:Pt:^Patient:-:PROMIS


name: PROMIS short form - social isolation 8a - version 2.0 raw score


name: Provider has a national provider ID:Find:Pt:Provider:Ord


name: Provider preference for care action:Find:Pt:^Patient:Nom


name: Provider satisfaction with healthcare delivery


name: Provider satisfaction with healthcare delivery:Find:Pt:^Patient:Nom


name: Start date for episode of care:Date:Pt:^Patient:Qn


name: State notifiable condition case identifier:ID:Pt:^Event:Nom


name: Patient died from illness of interest:Find:Pt:^Patient:Ord


name: Patient preference for care action:Find:Pt:^Patient:Nom


name: Patient satisfaction with healthcare delivery:Find:Pt:^Patient:Nom


name: Patient satisfaction with healthcare delivery


name: Hospitalized for condition of interest:Find:Pt:^Patient:Ord


name: PROMIS short form - alcohol - positive consequences 7a - version 1.0:-:30D:^Patient:-:PROMIS


name: PROMIS short form - alcohol - positive consequences 7a - version 1.0 raw score


name: PROMIS short form - alcohol - positive consequences 7a - version 1.0 raw score:Score:Pt:^Patient:Qn:PROMIS


name: PROMIS short form - alcohol - positive expectancies 7a - version 1.0


name: PROMIS short form - alcohol - positive expectancies 7a - version 1.0:-:30D:^Patient:-:PROMIS


name: PROMIS short form - alcohol - positive expectancies 7a - version 1.0 raw score


name: PROMIS short form - alcohol - positive expectancies 7a - version 1.0 raw score:Score:Pt:^Patient:Qn:PROMIS


name: PROMIS short form - companionship 4a - version 2.0:-:Pt:^Patient:-:PROMIS


name: PROMIS short form - companionship 4a - version 2.0


name: PROMIS short form - companionship 4a - version 2.0 raw score


name: PROMIS short form - companionship 4a - version 2.0 raw score:Score:Pt:^Patient:Qn:PROMIS


name: PROMIS short form - companionship 6a - version 2.0:-:Pt:^Patient:-:PROMIS


name: PROMIS short form - companionship 6a - version 2.0


name: PROMIS short form - companionship 6a - version 2.0 raw score:Score:Pt:^Patient:Qn:PROMIS


name: PROMIS short form - companionship 6a - version 2.0 raw score


name: PROMIS short form - emotional distress - anger 8a - version 1.0 raw score:Score:Pt:^Patient:Qn:PROMIS


name: PROMIS short form - emotional distress - anger 8a - version 1.0 raw score


name: PROMIS short form - emotional distress - anxiety 4a - version 1.0:-:Pt:^Patient:-:PROMIS


name: PROMIS short form - emotional distress - anxiety 4a - version 1.0


name: PROMIS short form - emotional distress - anxiety 4a - version 1.0 raw score:Score:Pt:^Patient:Qn:PROMIS


name: PROMIS short form - emotional distress - anxiety 4a - version 1.0 raw score


name: PROMIS short form - emotional distress - anxiety 7a - version 1.0 raw score:Score:Pt:^Patient:Qn:PROMIS


name: PROMIS short form - emotional distress - anxiety 7a - version 1.0 raw score


name: PROMIS short form - emotional distress - depression 4a - version 1.0


name: PROMIS short form - emotional distress - depression 4a - version 1.0 raw score:Score:Pt:^Patient:Qn:PROMIS


name: PROMIS short form - emotional distress - depression 4a - version 1.0 raw score


name: PROMIS short form - emotional distress - depression 8b - version 1.0 raw score


name: PROMIS short form - emotional distress - depression 8b - version 1.0 raw score:Score:Pt:^Patient:Qn:PROMIS


name: PROMIS short form - emotional support 4a - version 2.0:-:Pt:^Patient:-:PROMIS


name: PROMIS short form - emotional support 4a - version 2.0


name: PROMIS short form - emotional support 6a - version 2.0:-:Pt:^Patient:-:PROMIS


name: PROMIS short form - emotional support 6a - version 2.0


name: PROMIS short form - emotional support 6a - version 2.0 raw score


name: PROMIS short form - emotional support 6a - version 2.0 raw score:Score:Pt:^Patient:Qn:PROMIS


name: PROMIS short form - emotional support 8a - version 2.0:-:Pt:^Patient:-:PROMIS


name: PROMIS short form - emotional support 8a - version 2.0


name: PROMIS short form - emotional support 8a - version 2.0 raw score


name: PROMIS short form - emotional support 8a - version 2.0 raw score:Score:Pt:^Patient:Qn:PROMIS


name: albumin renal clearance in 24 hour (procedure)


name: PROMIS short form - instrumental support 8a - version 2.0 raw score


name: PROMIS short form - instrumental support 8a - version 2.0 raw score:Score:Pt:^Patient:Qn:PROMIS


name: PROMIS short form - satisfaction with participation in social roles 7a - version 1.0 raw score


name: PROMIS short form - satisfaction with participation in social roles 7a - version 1.0 raw score:Score:Pt:^Patient:Qn:PROMIS


name: PROMIS short form - pain interference 6b - version 1.0 raw score


name: PROMIS short form - pain interference 6b - version 1.0 raw score:Score:Pt:^Patient:Qn:PROMIS


name: PROMIS pediatric short form - fatigue 10a - version 1.0 raw score


name: PROMIS pediatric short form - fatigue 10a - version 1.0 raw score:Score:Pt:^Patient:Qn:PROMIS.PEDS


name: PROMIS pediatric short form - asthma 8a - version 1.0 raw score


name: PROMIS pediatric short form - asthma 8a - version 1.0 raw score:Score:Pt:^Patient:Qn:PROMIS.PEDS


name: PROMIS pediatric short form - physical function - mobility 8a - version 1.0 raw score


name: PROMIS pediatric short form - physical function - mobility 8a - version 1.0 raw score:Score:Pt:^Patient:Qn:PROMIS.PEDS


name: PROMIS pediatric short form - depressive symptoms - version 1.0 raw score


name: PROMIS pediatric short form - depressive symptoms - version 1.0 raw score:Score:Pt:^Patient:Qn:PROMIS.PEDS


name: Earliest date of diagnosis:Date:Pt:^Patient:Qn


name: Case is associated with a known outbreak


name: anion gap 3 in serum or plasma (lab test)


name: aptt in platelet poor plasma by coagulation assay


name: Pulse wave velocity:Vel:Pt:Arterial system:Qn


name: Lymph node involvement:Find:Pt:Lymph node:Ord


name: APTA Registry provider data panel:-:-:Provider:-


name: PROMIS short form - satisfaction with participation in social roles 4a - version 1.0 raw score:Score:Pt:^Patient:Qn:PROMIS


name: PROMIS short form - sleep impairment 8a - version 1.0 raw score


name: PROMIS short form - sleep impairment 8a - version 1.0 raw score:Score:Pt:^Patient:Qn:PROMIS


name: PROMIS short form - satisfaction with participation in DSA 7a - version 1.0 raw score


name: PROMIS short form - satisfaction with participation in DSA 7a - version 1.0 raw score:Score:Pt:^Patient:Qn:PROMIS


name: PROMIS short form - pain behavior 7a - version 1.0 raw score


name: PROMIS short form - pain behavior 7a - version 1.0 raw score:Score:Pt:^Patient:Qn:PROMIS


name: PROMIS pediatric short form - emotional distress - anxiety 8b - version 1.1


name: PROMIS pediatric short form - emotional distress - anxiety 8b - version 1.1:-:1W:^Patient:-:PROMIS.PEDS


name: Poly(ADP-Ribose) Polymerase Inhibitor [EPC]


name: Illness or injury end date:Date:Pt:^Patient:Qn


name: Immediate national notifiable condition:Find:Pt:^Event:Ord


name: herbal medicines bifidobacterium infantis


name: R wave amplitude.V6+S wave amplitude.V1:Elpot:Pt:Heart:Qn:EKG


name: RR interval.coefficient of variation:TRto:Procedure dur:Heart:Qn:EKG


name: State notifiable condition case identifier


name: State or province of exposure to illness:Loc:Pt:^Patient:Nom


name: State or province of exposure to illness


name: Surgical history relevant to physical therapy ICD9 diagnosis code


name: Surgical history relevant to physical therapy ICD9 diagnosis code:Type:Pt:^Patient:Nom


name: Physical therapist registry ID:ID:Pt:Provider:Nom


name: Physical therapy billing diagnosis code:Type:Pt:^Patient:Nom


name: Physical therapy conclusion of care panel:-:Pt:^Patient:-


name: Physical therapy conclusion of care panel


name: Physical therapy initial visit panel:-:Pt:^Patient:-


name: Physical therapy organization registry ID:ID:Pt:Organization:Nom


name: Physical therapy organization registry ID


name: Physical therapy reexamination panel:-:Pt:^Patient:-


name: Physical therapy subsequent visit panel:-:Pt:^Patient:-


name: Pregnancy status at time of illness or condition


name: Pregnancy status at time of illness or condition:Find:Pt:^Patient:Ord


name: PROMIS short form - fatigue 4a - version 1.0:-:Pt:^Patient:-:PROMIS


name: PROMIS short form - fatigue 4a - version 1.0


name: PROMIS short form - fatigue 4a - version 1.0 raw score


name: PROMIS short form - fatigue 4a - version 1.0 raw score:Score:Pt:^Patient:Qn:PROMIS


name: PROMIS short form - fatigue 7a - version 1.0 raw score:Score:Pt:^Patient:Qn:PROMIS


name: PROMIS short form - fatigue 7a - version 1.0 raw score


name: PROMIS short form - global - version 1.1 raw score


name: PROMIS short form - global - version 1.1 raw score:Score:Pt:^Patient:Qn:PROMIS


name: PROMIS short form - informational support 4a - version 2.0:-:Pt:^Patient:-:PROMIS


name: PROMIS short form - informational support 4a - version 2.0


name: PROMIS short form - informational support 4a - version 2.0 raw score


name: PROMIS short form - informational support 4a - version 2.0 raw score:Score:Pt:^Patient:Qn:PROMIS


name: PROMIS short form - informational support 6a - version 2.0


name: PROMIS short form - informational support 6a - version 2.0:-:Pt:^Patient:-:PROMIS


name: PROMIS short form - informational support 6a - version 2.0 raw score:Score:Pt:^Patient:Qn:PROMIS


name: PROMIS short form - informational support 6a - version 2.0 raw score


name: PROMIS short form - informational support 8a - version 2.0:-:Pt:^Patient:-:PROMIS


name: PROMIS short form - informational support 8a - version 2.0


name: PROMIS short form - informational support 8a - version 2.0 raw score


name: PROMIS short form - informational support 8a - version 2.0 raw score:Score:Pt:^Patient:Qn:PROMIS


name: PROMIS short form - instrumental support 4a - version 2.0:-:Pt:^Patient:-:PROMIS


name: PROMIS short form - instrumental support 4a - version 2.0


name: PROMIS short form - instrumental support 4a - version 2.0 raw score


name: PROMIS short form - instrumental support 4a - version 2.0 raw score:Score:Pt:^Patient:Qn:PROMIS


name: PROMIS short form - instrumental support 6a - version 2.0


name: PROMIS short form - instrumental support 6a - version 2.0:-:Pt:^Patient:-:PROMIS


name: PROMIS short form - instrumental support 6a - version 2.0 raw score


name: PROMIS short form - instrumental support 6a - version 2.0 raw score:Score:Pt:^Patient:Qn:PROMIS


name: PROMIS short form - instrumental support 8a - version 2.0:-:Pt:^Patient:-:PROMIS


name: PROMIS short form - instrumental support 8a - version 2.0


name: PROMIS short form - pain intensity 3a - version 1.0 raw score:Score:Pt:^Patient:Qn:PROMIS


name: PROMIS short form - pain intensity 3a - version 1.0 raw score


name: PROMIS short form - pain interference 8a - version 1.0 raw score:Score:Pt:^Patient:Qn:PROMIS


name: Medical history relevant to physical therapy treatment:Type:Pt:^Patient:Nom


name: Medical history relevant to physical therapy treatment


name: Episode of care unique identifier:ID:Pt:^Patient:Nom


name: APTA Registry patient registration panel


name: APTA Registry patient registration panel:-:-:^Patient:-


name: American Physical Therapy Association Registry panel


name: American Physical Therapy Association Registry panel:-:Pt:Organization:-


name: Whether requested procedure is appropriate


name: Country of usual residence:Loc:Pt:^Patient:Nom


name: Case is associated with a known outbreak:Find:Pt:^Event:Ord


name: Fetal chromosome 13 trisomy:PrThr:Pt:Plas.cfDNA:Ord:Sequencing


name: PROMIS item bank - companionship - version 2.0


name: PROMIS item bank - companionship - version 2.0:-:Pt:^Patient:-:PROMIS


name: Dyskinesia duration per D:Find:1W:^Patient:Ord:UPDRS


name: PROMIS short form - alcohol - negative expectancies 7a - version 1.0 raw score


name: PROMIS short form - alcohol - negative expectancies 7a - version 1.0 raw score:Score:Pt:^Patient:Qn:PROMIS


name: PROMIS short form - social isolation 6a - version 2.0 raw score


name: PROMIS short form - social isolation 6a - version 2.0 raw score:Score:Pt:^Patient:Qn:PROMIS


name: PROMIS short form - physical function 20a - version 1.0 raw score


name: PROMIS short form - physical function 20a - version 1.0 raw score:Score:Pt:^Patient:Qn:PROMIS


name: Earliest date reported to county:TmStp:Pt:^Event:Qn


name: Social connection and isolation panel:-:Pt:^Patient:-


name: Weight management summary report:Find:Pt:{Setting}:Doc:{Role}


name: PROMIS item bank - informational support - version 2.0


name: PROMIS item bank - informational support - version 2.0:-:Pt:^Patient:-:PROMIS


name: Noninvasive arteriosclerosis studies panel


name: Noninvasive arteriosclerosis studies panel:-:Pt:Arterial system:Qn


name: APTA Registry patient episode of care panel


name: APTA Registry patient episode of care panel:-:-:^Patient:-


name: PROMIS item bank - emotional support - version 2.0


name: PROMIS item bank - emotional support - version 2.0:-:Pt:^Patient:-:PROMIS


name: PROMIS short form - physical function 4a - version 1.0


name: PROMIS short form - physical function 4a - version 1.0:-:Pt:^Patient:-:PROMIS


name: PROMIS short form - satisfaction with participation in social roles 8a - version 1.0


name: PROMIS short form - satisfaction with participation in social roles 8a - version 1.0:-:1W:^Patient:-:PROMIS


name: PROMIS short form - social isolation 4a - version 2.0


name: PROMIS short form - social isolation 4a - version 2.0:-:Pt:^Patient:-:PROMIS


name: PROMIS item bank - alcohol - alcohol use - version 1.0


name: PROMIS item bank - alcohol - alcohol use - version 1.0:-:Pt:^Patient:-:PROMIS


name: PROMIS short form - alcohol - negative expectancies 7a - version 1.0


name: Body structure ICF code:Find:Pt:^Patient:Nom


name: Current severity of limitation:Find:Pt:^Patient:Ord


name: Earliest date reported to state:TmStp:Pt:^Event:Qn


name: Body function ICF code:Find:Pt:^Patient:Nom


name: Case investigation start date:Date:Pt:^Event:Qn


name: Date of first report to public health department


name: Date of first report to public health department:TmStp:Pt:^Event:Qn


name: Is the patient breastfed:Find:Pt:^Patient:Ord


name: Is the patient fed something other than breast milk or formula


name: Is the patient fed something other than breast milk or formula:Find:Pt:^Patient:Ord


name: PROMIS short form - social isolation 8a - version 2.0


name: Reason care action performed or not:Find:Pt:^Patient:Nom


name: Weight management summary - recommended IHE set


name: Weight management summary - recommended IHE set:-:Pt:{Setting}:-


name: Probability of suspected pulmonary embolism prior to imaging:Likelihood:Pt:^Patient:Ord


name: Probability of suspected pulmonary embolism prior to imaging


name: Procedure that confirmed birth defect diagnosis:Type:Pt:^Patient:Nom


name: Procedure that confirmed birth defect diagnosis


name: Projected goal of limitation:Find:Pt:^Patient:Ord


name: PROMIS item bank - ability to participate in social roles and activities - version 2.0


name: PROMIS item bank - ability to participate in social roles and activities - version 2.0:-:Pt:^Patient:-:PROMIS


name: PROMIS item bank - alcohol - negative expectancies - version 1.0


name: PROMIS item bank - alcohol - negative expectancies - version 1.0:-:Pt:^Patient:-:PROMIS


name: PROMIS item bank - alcohol - positive expectancies - version 1.0:-:To identify measures at a point in time:^Patient:-:PROMIS


name: PROMIS item bank - alcohol - positive expectancies - version 1.0


name: PROMIS item bank - alcohol - positive outcomes - version 1.0


name: PROMIS item bank - alcohol - positive outcomes - version 1.0:-:Pt:^Patient:-:PROMIS


name: PROMIS item bank - instrumental support - version 2.0:-:Pt:^Patient:-:PROMIS


name: PROMIS item bank - instrumental support - version 2.0


name: PROMIS item bank - satisfaction with social roles and activities - version 2.0


name: PROMIS item bank - satisfaction with social roles and activities - version 2.0:-:Pt:^Patient:-:PROMIS


name: PROMIS item bank - social isolation - version 2.0


name: PROMIS item bank - social isolation - version 2.0:-:Pt:^Patient:-:PROMIS


name: PROMIS parent proxy mobility - version 1.0 T-score:Tscore:Pt:^Patient:Qn:PROMIS.PARENTPROXY


name: PROMIS parent proxy mobility - version 1.0 T-score


name: PROMIS pediatric physical function: mobility - version 1.0 T-score


name: PROMIS short form - physical function 10a - version 1.0 raw score


name: PROMIS short form - physical function 10a - version 1.0 raw score:Score:Pt:^Patient:Qn:PROMIS


name: PROMIS short form - physical function 20a - version 1.0:-:Pt:^Patient:-:PROMIS


name: PROMIS short form - physical function 20a - version 1.0


name: PROMIS short form - physical function 4a - version 1.0 raw score:Score:Pt:^Patient:Qn:PROMIS


name: PROMIS short form - physical function 4a - version 1.0 raw score


name: PROMIS short form - physical function 6b - version 1.2:-:Pt:^Patient:-:PROMIS


name: PROMIS short form - physical function 6b - version 1.2


name: PROMIS short form - physical function 6b - version 1.2 raw score


name: PROMIS short form - physical function 6b - version 1.2 raw score:Score:Pt:^Patient:Qn:PROMIS


name: PROMIS short form - physical function 8b - version 1.2 raw score


name: PROMIS short form - physical function 8b - version 1.2 raw score:Score:Pt:^Patient:Qn:PROMIS


name: PROMIS short form - satisfaction with participation in social roles 8a - version 1.0 raw score:Score:Pt:^Patient:Qn:PROMIS


name: PROMIS short form - satisfaction with participation in social roles 8a - version 1.0 raw score


name: PROMIS short form - satisfaction with social roles and activities 4a - version 2.0


name: PROMIS short form - satisfaction with social roles and activities 4a - version 2.0:-:Pt:^Patient:-:PROMIS


name: PROMIS short form - satisfaction with social roles and activities 6a - version 2.0


name: PROMIS short form - satisfaction with social roles and activities 6a - version 2.0:-:Pt:^Patient:-:PROMIS


name: PROMIS short form - satisfaction with social roles and activities 6a - version 2.0 raw score:Score:Pt:^Patient:Qn:PROMIS


name: PROMIS short form - satisfaction with social roles and activities 6a - version 2.0 raw score


name: Whether requested procedure is appropriate:Find:Pt:^Patient:Ord


name: APTA Registry identifiers panel:ID:Pt:Organization:Nom:APTA


name: PROMIS short form - alcohol - negative consequences 7a - version 1.0 raw score


name: PROMIS short form - alcohol - negative consequences 7a - version 1.0 raw score:Score:Pt:^Patient:Qn:PROMIS


name: PROMIS short form - sleep disturbance 4a - version 1.0 raw score


name: PROMIS short form - sleep disturbance 4a - version 1.0 raw score:Score:Pt:^Patient:Qn:PROMIS


name: PROMIS pediatric short form - physical function - upper extremity 8a - version 1.0 raw score


name: PROMIS pediatric short form - physical function - upper extremity 8a - version 1.0 raw score:Score:Pt:^Patient:Qn:PROMIS.PEDS


name: PROMIS short form - ability to participate in social roles and activities 8a - version 2.0


name: PROMIS short form - ability to participate in social roles and activities 8a - version 2.0:-:Pt:^Patient:-:PROMIS


name: PROMIS short form - social isolation 4a - version 2.0 raw score


name: PROMIS short form - social isolation 4a - version 2.0 raw score:Score:Pt:^Patient:Qn:PROMIS


name: APTA Registry organization data panel:-:Pt:Organization:-:APTA


name: PROMIS short form - social isolation 6a - version 2.0


name: PROMIS short form - social isolation 6a - version 2.0:-:Pt:^Patient:-:PROMIS


name: PROMIS short form - alcohol - negative consequences 7a - version 1.0


name: PROMIS short form - alcohol - negative consequences 7a - version 1.0:-:30D:^Patient:-:PROMIS


name: PROMIS short form - alcohol - alcohol use 7a - version 1.0 raw score


name: PROMIS short form - alcohol - alcohol use 7a - version 1.0 raw score:Score:Pt:^Patient:Qn:PROMIS


name: PROMIS short form - sleep disturbance 6a - version 1.0 raw score


name: PROMIS short form - sleep disturbance 6a - version 1.0 raw score:Score:Pt:^Patient:Qn:PROMIS


name: PROMIS pediatric short form - emotional distress - anxiety 8a - version 1.0 raw score


name: PROMIS pediatric short form - emotional distress - anxiety 8a - version 1.0 raw score:Score:Pt:^Patient:Qn:PROMIS.PEDS


name: PROMIS short form - alcohol - negative expectancies 7a - version 1.0:-:Pt:^Patient:-:PROMIS


name: PROMIS short form - sleep disturbance 8b - version 1.0 raw score


name: PROMIS short form - sleep disturbance 8b - version 1.0 raw score:Score:Pt:^Patient:Qn:PROMIS


name: PROMIS pediatric short form - pain interference 8a - version 1.0 raw score


name: PROMIS pediatric short form - pain interference 8a - version 1.0 raw score:Score:Pt:^Patient:Qn:PROMIS.PEDS


name: Date of initial report:TmStp:Pt:^Event:Qn


name: Age at time of case investigation:Time:Pt:^Patient:Qn


name: PROMIS short form - alcohol - positive consequences 7a - version 1.0


name: PROMIS physical function w mobility aids - version 1.0 T-score


name: PROMIS physical function w mobility aids - version 1.0 T-score:Tscore:Pt:^Patient:Qn:PROMIS


name: PROMIS short form - ability to participate in social roles and activities 8a - version 2.0 raw score


name: PROMIS short form - ability to participate in social roles and activities 8a - version 2.0 raw score:Score:Pt:^Patient:Qn:PROMIS


name: PROMIS pediatric short form - peer relationships 8a - version 1.0 raw score


name: PROMIS pediatric short form - peer relationships 8a - version 1.0 raw score:Score:Pt:^Patient:Qn:PROMIS.PEDS


name: PROMIS pediatric short form - emotional distress - anger - version 1.0 raw score


name: PROMIS pediatric short form - emotional distress - anger - version 1.0 raw score:Score:Pt:^Patient:Qn:PROMIS.PEDS


name: City of exposure to illness:Loc:Pt:^Patient:Nom


name: Yesterday, what percent of snacks were healthy:NFr:1D:^Patient:Qn


name: Yesterday, what percent of snacks were healthy


name: Organization episode of care unique identifier


name: Organization episode of care unique identifier:ID:Pt:^Patient:Nom


name: PROMIS short form - alcohol - alcohol use 7a - version 1.0


name: PROMIS short form - alcohol - alcohol use 7a - version 1.0:-:30D:^Patient:-:PROMIS


name: PROMIS short form - satisfaction with social roles and activities 8a - version 2.0:-:Pt:^Patient:-:PROMIS


name: PROMIS short form - satisfaction with social roles and activities 8a - version 2.0


name: {7 (vilazodone hydrochloride 10 MG Oral Tablet) / 23 (vilazodone hydrochloride 20 MG Oral Tablet) } Pack


name: AVOBENZONE 0.6 g in 100 mL / OCTINOXATE 3 g in 100 mL / OCTOCRYLENE 3 g in 100 mL TOPICAL SOLUTION [Time Frame Future Resist Foundation Broad Spectrum SPF 20 Truffle Delilah Cosmetics]


name: TITANIUM DIOXIDE 1.42 g in 100 mL / ZINC OXIDE 20 g in 100 mL TOPICAL CREAM [CC Daily Correct Broad Spectrum SPF 35 Sunscreen Medium to Dark Supergoop]


name: AVOBENZONE 3 g in 100 mL / OCTINOXATE 7.5 g in 100 mL / OCTISALATE 5 g in 100 mL / OCTOCRYLENE 2.5 g in 100 mL TOPICAL CREAM [Anti-Aging Day Broad Spectrum SPF 30 La Prairie Group AG]


name: HOMOSALATE 5 g in 100 mL / OCTINOXATE 7.5 g in 100 mL / OCTISALATE 5 g in 100 mL / AVOBENZONE 3 g in 100 mL / OCTOCRYLENE 2.75 g in 100 mL TOPICAL LOTION [SOLEIL FORTE MULTI]


name: TITANIUM DIOXIDE 2 g in 100 mL / ZINC OXIDE 8 g in 100 mL / OCTINOXATE 7.5 g in 100 mL / OCTISALATE 5 g in 100 mL TOPICAL LOTION [DD TZ FORTE]


name: dextromethorphan / menthol / phenylephrine


name: {1 (24 HR quetiapine 200 MG Extended Release Oral Tablet) / 11 (24 HR quetiapine 300 MG Extended Release Oral Tablet) / 3 (24 HR quetiapine 50 MG Extended Release Oral Tablet) } Pack


name: {1 (24 HR quetiapine 200 MG Extended Release Oral Tablet [Seroquel]) / 11 (24 HR quetiapine 300 MG Extended Release Oral Tablet [Seroquel]) / 3 (24 HR quetiapine 50 MG Extended Release Oral Tablet [Seroquel]) } Pack [Seroquel XR 14-Day Sample Kit]


name: DRESSING,CALCICARE CALCIUM ALGINATE 4IN X 4.75IN H#529937R


name: DRESSING,CALCICARE CALCIUM ALGINATE 4IN X 8IN H#529939R


name: BRIEF,BARIATRIC UNDERWEAR XX-LARGE ATTENDS


name: CATHETER,SELF-CATH CLOSED SYSTEM 14FR COLOPLAST #2614


name: SUCTION CANISTER 1200ML MEDI-VAC #65651212


name: TRACH-VENT T HME W/5MM COLLAR TELEFLEX #41131


name: TITANIUM DIOXIDE 0.21000 g in 30 mL / ZINC OXIDE 1.42500 g in 30 mL TOPICAL LOTION [RODAN and FIELDS UNBLEMISH]


name: TITANIUM DIOXIDE 40.25 mg in 1 mL TOPICAL CREAM [Artistry Exact Fit Longwearing Foundation SPF 15 Broad Spectrum Sunscreen]


name: TITANIUM DIOXIDE 0.38400 g in 4 g / ZINC OXIDE 0.19600 g in 4 g TOPICAL POWDER [RODAN and FIELDS ENHANCEMENTS MEDIUM]


name: TITANIUM DIOXIDE 9.95 g in 100 g / ZINC OXIDE 3.72 g in 100 g TOPICAL CREAM [Sente Daily Repair Complex SPF 30]


name: Comfort Assist Insulin Syr 0.3cc 30g 0.3125"


name: Comfort Assist Insulin Syr 0.3cc 31g 0.3125"


name: Comfort Assist Insulin Syr 0.5cc 30g 0.3125"


name: Comfort Assist Insulin Syr 0.5cc 31g 0.3125"


name: Comfort Assist Insulin Syr 1cc 30g 0.3125"


name: Comfort Assist Insulin Syr 1cc 31g 0.3125'


name: Comfort Assist Insulin Syringe 0.3cc 29g 0.5"


name: {1 (bisacodyl 5 MG Delayed Release Oral Tablet) / 1 (2000 ML) (polyethylene glycol 3350 210000 MG / potassium chloride 740 MG / sodium bicarbonate 2860 MG / sodium chloride 5600 MG Powder for Oral Solution [Gavilyte-H]) } Pack [Gavilyte-H and Bisacodyl]


name: ENSULIZOLE 20 mg in 1 mL / OCTINOXATE 50 mg in 1 mL / ZINC OXIDE 54.9 mg in 1 mL TOPICAL CREAM [Artistry Beauty Balm Perfecting Primer SPF 35 Broad Spectrum Sunscreen]


name: ENSULIZOLE 20 mg in 1 mL / OCTINOXATE 55 mg in 1 mL / OXYBENZONE 5 mg in 1 mL / TITANIUM DIOXIDE 8.8 mg in 1 mL / ZINC OXIDE 98 mg in 1 mL TOPICAL CREAM [Artistry Ideal Radiance Illuminating CC SPF 50 Broad Spectrum Sunscreen Light/Medium]


name: ENSULIZOLE 20 mg in 1 mL / OCTINOXATE 55 mg in 1 mL / OXYBENZONE 5 mg in 1 mL / TITANIUM DIOXIDE 8.8 mg in 1 mL / ZINC OXIDE 98 mg in 1 mL TOPICAL CREAM [Artistry Ideal Radiance Illuminating CC SPF 50 Broad Spectrum Sunscreen Medium]


name: Zinc Oxide 21 g in 100 g TOPICAL CREAM [Live Ultimate Facial Sunscreen SPF30 SPF 30]


name: Medical Food Oral Powder [PhenylAde GMP]


name: Calcium Alginate/Carboxymethylcellulose/Silver Topical application Dressing [Silvercel Antimicrobial Alginate]


name: Collagen/Oxidized Regenerated Cellulose 55%-45% Topical application Dressing [Promogran]


name: Collagen/Oxidized Regenerated Cellulose/Silver 55%-44%-1% Topical application Dressing [Promogran Prisma]


name: Calcium Alginate/Carboxymethylcellulose Topical application Dressing


name: Calcium Alginate/Carboxymethylcellulose/Silver Topical application Dressing


name: Collagen/Oxidized Regenerated Cellulose 55%-45% Topical application Dressing


name: Collagen/Oxidized Regenerated Cellulose/Silver 55%-44%-1% Topical application Dressing


name: Calcium Alginate/Carboxymethylcellulose Topical application Dressing [Nu-Derm Alginate]


name: pediatric nutrit,milk based,iron/docosahex.acid/arachid.acid 4 gram-8 gram-16 gram/150 kcal ORAL POWDER (GRAM)


name: polyquaternium-6/gauze bandage 0.3 %-1" X 5 yard TOPICAL STRIP


name: colostomy bag, non-sterile 1 3/16" (8") MISCELL EACH


name: colostomy bag, non-sterile 1 3/8" (8") MISCELL EACH


name: colostomy bag, non-sterile 1 9/16" (8") MISCELL EACH


name: colostomy bag, non-sterile 1" (8") MISCELL EACH


name: colostomy bag, non-sterile 13/16"-2 3/4" (8") MISCELL EACH


name: infant formula with iron/docosahexaenoic acid/arachidonic ac 2.1 gram-5.4 gram-11.1 gram/100 kcal ORAL CONCENTRATE, ORAL


name: infant formula with iron/docosahexaenoic acid/arachidonic ac 2.2 gram-5.4 gram-11 gram/100 kcal ORAL POWDER (GRAM)


name: nutritional supplement/fiber ORAL LIQUID (GRAM)


name: nutritional therapy for phenylketonuria(PKU) with iron no.57 30 gram-396 kcal/100 gram ORAL POWDER (GRAM)


name: nutritional therapy for phenylketonuria(PKU) with iron no.57 30 gram-396 kcal/100 gram ORAL POWDER IN PACKET (EA)


name: Ensure Active High Prot for Musc Health Choc


name: Ensure Active High Prot for Musc Health Van


name: Ensure Active High Protein for Muscle Health


name: AVOBENZONE 2 g in 100 mL / OCTINOXATE 7.5 g in 100 mL / OCTISALATE 5 g in 100 mL / OCTOCRYLENE 7 g in 100 mL / OXYBENZONE 5 g in 100 mL TOPICAL CREAM [Ray Defense Broad Spectrum SPF 30]


name: Pedialyte Electrolyte Powder for Solution (Strawberry Lemonade)


name: Homosalate 3.5 g in 50 mL / Octisalate 2.5 g in 50 mL / Avobenzone 1.5 g in 50 mL TOPICAL CREAM [BEAUTY BEFORE AGE AHAVA UPLIFT DAY broad spectrum SPF 20]


name: OCTINOXATE 7.5 g in 100 mL / OCTOCRYLENE 8 g in 100 mL / OXYBENZONE 3 g in 100 mL / TITANIUM DIOXIDE 5 g in 100 mL TOPICAL CREAM [Exel Clarifying Line SPF 50]


name: OCTINOXATE 75 mg in 1 g / MERADIMATE 50 mg in 1 g / OXYBENZONE 50 mg in 1 g / OCTISALATE 50 mg in 1 g CUTANEOUS LOTION [PRO-TECT SUNSCREEN FOR PROFESSIONALS]


name: {24 (ethinyl estradiol 0.025 MG / norethindrone 0.8 MG Chewable Tablet) / 4 (ferrous fumarate 75 MG Chewable Tablet) } Pack [Layolis Fe 28]


name: maltodextrin/xanthan gum ORAL POWDER (GRAM)


name: maltodextrin/xanthan gum ORAL POWDER IN PACKET (EA)


name: nut.therapy, phenylketonuria(PKU) with iron, no.57


name: Proteinex Predigested Liquid Black Cherry


name: {150 (doxycycline monohydrate 100 MG Oral Tablet) / 1 (118 ML) (salicylic acid 20 MG/ML Medicated Liquid Soap) } Pack


name: Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor


name: Cyclopentasiloxane, Polyethylene Glycol Bulk powder


name: saliva collection device/ibuprofen 600 mg ORAL KIT


name: subcu insulin pump, continuous glucose mon. system


name: sodium/potassium/chloride/dextrose 10.6 mEq-4.7 mEq-8.3 mEq-6 gram/9 gram ORAL POWDER IN PACKET (EA)


name: Octinoxate/Zinc Oxide 3%-11% Topical application Cream [Vanicream Sunscreen Sport]


name: Anti-Addiction/ Substance Abuse Treatment Agents


name: Anti-HIV Agents, Non-nucleoside Reverse Transcriptase Inhibitors (NNRTI)


name: Anti-HIV Agents, Nucleoside and Nucleotide Reverse Transcriptase Inhibitors (NRTI)


name: Anti-HIV Agents, Integrase Inhibitors (INSTI)


name: Dyslipidemics, HMG CoA Reductase Inhibitors


name: Attention Deficit Hyperactivity Disorder Agents, Amphetamines


name: Hormonal Agents, Stimulant/ Replacement/ Modifying (Adrenal)


name: Hormonal Agents, Stimulant/Replacement/ Modifying (Pituitary)


name: Hormonal Agents, Stimulant/ Replacement/ Modifying (Prostaglandins)


name: Hormonal Agents, Stimulant/Replacement/ Modifying (Thyroid)


name: Ophthalmic Prostaglandin and Prostamide Analogs


name: Phosphodiesterase Inhibitors, Airways Disease


name: Hormonal Agents, Stimulant/ Replacement/ Modifying (Sex Hormones/ Modifiers)


name: Attention Deficit Hyperactivity Disorder Agents, Non-amphetamines


name: Abnormal erythroid lineage cell morphology


name: Low maternal circulating chorionic gonadotropin concentration


name: High maternal circulating chorionic gonadotropin concentration


name: Abnormal circulating calcium concentration


name: Maternal anticardiolipin antibody positive


name: Low maternal circulating PAPP-A concentration


name: Elevated maternal circulating alpha-fetoprotein concentration


name: Low maternal circulating alpha-fetoprotein concentration


name: Low maternal circulating estriol concentration


name: Genetic anticipation with paternal anticipation bias


name: Japanese translation of the Medical Subject Headings, 2014


name: OCTINOXATE 75 mg in 1 g / MERADIMATE 50 mg in 1 g / OXYBENZONE 30 mg in 1 g / OCTISALATE 50 mg in 1 g CUTANEOUS LOTION [PRO-TECT SPORTS SUNSCREEN]


name: Avitene Microfibrillar Hemostat, topical powder


name: DRESSING,BIATAIN 3D ADHESIVE FOAM 5IN X 5IN


name: DRESSING,BIATAIN 3D ADHESIVE FOAM 7IN X 7IN


name: DRESSING,BIATAIN SILICONE ADHESIVE FOAM 7IN X 7IN


name: INCONT LINER,EXTRA HEAVY,SURECARE #1130A


name: INCONT LINER,MENS,EXTRA HEAVY,SURECARE #23246A


name: MIXING DEVICE,PARATHYROID HORMONE CARTRIDGE


name: VAD DRIVELINE MAINTENANCE KIT CM#DT19375


name: CONTACT LENS CLEANING (BOSTON ADVANCE) SOLN


name: CONTACT LENS CLEANING (PEROXICLEAR) SOLN


name: betamethasone / hydroquinone / tretinoin


name: ALLANTOIN 0.5 mg in 100 mg TOPICAL TABLET, SOLUBLE [Gene 16 Whitening Factor]


name: NIACINAMIDE 0.3 in 100 g / SALICYLIC ACID 0.5 in 100 g topical LIQUID [Ecosom Tonic]


name: AVOBENZONE 25.76 mg in 1 mL / HOMOSALATE 85.87 mg in 1 mL / OCTOCRYLENE 34.34 mg in 1 mL / OCTISALATE 39.07 mg in 1 mL / OXYBENZONE 42.94 mg in 1 mL TOPICAL SPRAY [Coppertone Kids SPF 50]


name: HOMOSALATE 118.2 mg in 1 mL / OCTISALATE 39.43 mg in 1 mL / OXYBENZONE 52 mg in 1 mL / AVOBENZONE 26 mg in 1 mL TOPICAL SPRAY [coppertone Sunscreen Oil Free SFP 50]


name: OXYBENZONE 34.35 mg in 1 mL / OCTOCRYLENE 17.18 mg in 1 mL / OCTISALATE 39.08 mg in 1 mL / AVOBENZONE 25.76 mg in 1 mL / HOMOSALATE 85.88 mg in 1 mL TOPICAL SPRAY [coppertone sport Sunscreen SPF 30]


name: TRICHLORMETHIAZIDE 495 g in 500 g NOT APPLICABLE POWDER [X]


name: PIMOBENDAN 1 kg in 1 kg NOT APPLICABLE POWDER


name: DECOQUINATE 247.5 g in 250 g NOT APPLICABLE POWDER [X]


name: DICLAZURIL 495 g in 500 g NOT APPLICABLE POWDER [X]


name: {24 (ethinyl estradiol 0.02 MG / norethindrone acetate 1 MG Oral Tablet) / 4 (ferrous fumarate 75 MG Oral Tablet) } Pack [Junel Fe 24 1/20 28 Day]


name: VORICONAZOLE 49.5 g in 50 g NOT APPLICABLE POWDER [X]


name: PREGABALIN 495 g in 500 g NOT APPLICABLE POWDER [X]


name: MARBOFLOXACIN 247.5 g in 250 g NOT APPLICABLE POWDER [X]


name: GUANABENZ ACETATE 24.75 g in 25 g NOT APPLICABLE POWDER [X]


name: PHENYLBUTAZONE 24750 g in 25000 g NOT APPLICABLE POWDER [X]


name: TITANIUM DIOXIDE 110 mg in 1 mL TOPICAL LOTION [La Roche Posay Laboratoire Dermatologique Anthelios 50 Tinted Mineral Sunscreen Broad Spectrum SPF 50]


name: choline / dextromethorphan / guaifenesin / phenylephrine


name: choline / diphenhydramine / phenylephrine


name: Culturelle Health and Wellness Vegetarian


name: Walgreens True Metrix Blood Glucose Test Strip


name: Walgreens True Metrix Self Monitoring Blood Glucose Monitor


name: Capsaicin;Diclofenac Sodium;Ranitidine Hydrochloride 0.025%; 75 MG; 150 MG Multiple Routes Kit [DermacinRx Inflammatral Pak]


name: Gmate Smart/Voice Blood Glucose Test Strips


name: ADENOSINE 0.0004 in 100 mL TOPICAL CREAM [PRIMEROSE SNAIL]


name: NIACINAMIDE 0.02 in 100 mL / DIMETHICONE 0.015 in 100 mL / ADENOSINE 0.0004 in 100 mL TOPICAL CREAM [PRIMEROSE EGF]


name: {1 (acetaminophen 500 MG / dextromethorphan hydrobromide 20 MG / phenylephrine hydrochloride 10 MG Granules for Oral Solution) / 1 (acetaminophen 650 MG / diphenhydramine hydrochloride 25 MG / phenylephrine hydrochloride 10 MG Granules for Oral Solution) } Pack


name: glycerides C12-18 100 % MISCELL PELLET (GRAM)


name: infant formula with iron, human milk fortifier 0.5 gram-7 kcal/5 mL ORAL LIQUID IN PACKET (ML)


name: TABLET, EXTENDED RELEASE 24 HR DOSE PACK


name: AVOBENZONE 30 mg in 1 mL / OCTINOXATE 75 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 27.5 mg in 1 mL TOPICAL LOTION [CHANTECAILLE Ultra Sun Protection Sunscreen Broad Spectrum SPF 45]


name: cardioplegic solution no.8 (hot shot A + B)


name: cardioplegic solution no.9 (warm induction A + B)


name: Bacitracin Zinc/Neomycin/Polymyxin B Sulfate;Ibuprofen 400 U/1 GM-3.5 MG/1 GM-5000 U/1 GM; 200 MG Multiple Routes Kit


name: Hyperpolarization-activated Cyclic Nucleotide-gated Channel Blocker


name: Hyaluronidase Human, Recombinant;Immune Globulin 160 U/1 ML; 10% Subcutaneous Solution [HyQvia]


name: Dimethicone;Triamcinolone Acetonide 5%; 0.1% Topical application Cream [DermacinRx SilaPak]


name: DIMETHICONE 0.025 in 80 mL / NIACINAMIDE 0.02 in 80 mL / PANTHENOL 0.005 in 80 mL / ADENOSINE 0.0004 in 80 mL TOPICAL CREAM [PRIMEROSE WHITE MILKY CB]


name: {21 (desogestrel 0.15 MG / ethinyl estradiol 0.02 MG Oral Tablet) / 5 (ethinyl estradiol 0.01 MG Oral Tablet) / 2 (inert ingredients 1 MG Oral Tablet) } Pack [Kimidess 28 Day]


name: extra-oral posterior dental radiographic image


name: collection and preparation of genetic sample material for laboratory analysis and report


name: genetic test for susceptibility to diseases - specimen analysis


name: application of caries arresting medicament - per tooth


name: autogenous connective tissue graft procedure (including donor and recipient surgical sites) - each additional contiguous tooth, implant or edentulous tooth position in same graft site


name: non-autogenous connective tissue graft procedure (including recipient surgical site and donor material) - each additional contiguous tooth, implant or edentulous tooth position in same graft site


name: immediate maxillary partial denture - resin base (including retentive/clasping materials, rests and teeth)


name: immediate mandibular partial denture - resin base (including retentive/clasping materials, rests and teeth)


name: immediate maxillary partial denture - cast metal framework with resin denture bases (including retentive/clasping materials, rests and teeth)


name: immediate mandibular partial denture - cast metal framework with resin denture bases (including retentive/clasping materials, rests and teeth)


name: removable orthodontic retainer adjustment


name: deep sedation/general anesthesia - each subsequent 15 minute increment


name: intravenous moderate (conscious) sedation/analgesia - each subsequent 15 minute increment


name: cleaning and inspection of removable complete denture, maxillary


name: cleaning and inspection of removable complete denture, mandibular


name: cleaning and inspection of removable partial denture, maxillary


name: cleaning and inspection of removable partial denture, mandibular


name: x-ray toes deformity phalanges hypoplasia


name: x-ray of unilateral ribs with chest, three or more views and PA chest views


name: x-ray of thoracic spine: butterfly vertebra


name: x-ray lumbosacral spine: butterfly vertebra


name: x-ray guidance for change of percutaneous tube with contrast


name: x-ray guidance for change of percutaneous tube


name: x-ray of cervical spine: butterfly vertebra


name: x-ray bone generalized cortical thickening


name: WPPSI-IV verbal comprehension index standard score


name: WPPSI-IV verbal comprehension index percentile score


name: WPPSI-IV verbal comprehension index confidence index


name: WPPSI-IV vocabulary acquisition index standard score


name: WPPSI-IV vocabulary acquisition index percentile


name: WPPSI-IV vocabulary acquisition index confidence index


name: WJ-III COG general intellectual ability standard score


name: WJ-III COG general intellectual ability percentile score


name: WJ-III COG general intellectual ability confidence index


name: WJ-III COG composite score verbal ability


name: WJ-III COG composite score general intellectual ability


name: WJ-III COG brief intellectual ability score


name: WJ-III COG brief intellectual ability standard score


name: WJ-III COG brief intellectual ability percentile score


name: WJ-III COG brief intellectual ability confidence index